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Scanning surveillance facilitates the monitoring of many endemic diseases in Great Britain, 
including sheep scab, an ectoparasitic disease of major economic and welfare burden. With 
emerging antiparasitic resistance making the development of control strategies particularly 
timely, this thesis aimed to enhance the use of data for the scanning surveillance of sheep 
scab, specifically to guide future control strategies. In Chapter 2 an existing source of 
scanning surveillance, positive skin scrape diagnoses ('positive scrapes') reported in the 
Veterinary Investigation Diagnosis Analysis (VIDA) database, were analysed to identify 
"hotspots" of disease for targeted control and evaluate a potential denominator to improve 
the interpretation of the count of positive scrapes. The details of all past targeted disease 
control initiatives were also collated and a temporal aberration detection algorithm (TADA) 
was applied to investigate their impact on positive scrape diagnoses. Then, in Chapter 3, data 
from a recently commercialised diagnostic test, the sheep scab ELISA, were collected and 
analysed, to explore its current use and uptake since commercialisation, identify risk factors 
for infestation and to consider its value as a complementary source of scanning surveillance. 
The results of this study showed a decline in positive scrapes, however, the positive scrapes 
as a proportion of submissions had remained stable. A strong seasonal pattern with high 
counts in winter was also observed. Wales was identified as a particular "hotspot", with the 
highest count of positive scrapes. Furthermore, two potential denominators 'scheduled 
scrapes' and 'skin submissions' were identified to provide further interpretation of positive 
scrapes. Finally, 11 disease control initiatives were identified and collated, and the TADA 
offered a framework to objectively measure the impact of these, showing 'free testing' 
initiatives had the most impact on positive scrape diagnoses. The sheep scab ELISA 
demonstrated a steady uptake since the beginning of testing, an established seasonal pattern 
and broad spatial uptake across England and Wales, with few submissions originating from 
Scotland. The recommended 12-sample submissions for monitoring were most frequently 
submitted; however, the majority of submissions originated from itchy sheep, showing this 
test is also widely used to diagnose sheep with clinical or subclinical signs. For the first time, 
double fencing was shown to significantly decrease the likelihood of a positive serostatus 
submission; however, common grazing was not identified as a risk factor. Ultimately, this 
project resulted in the creation of a new data source that could enhance the scanning 
surveillance of sheep scab. Using sheep scab as a model, the methods used here offer a 
framework to improve the use of existing and new data sources for the scanning surveillance 
of other endemic diseases.   
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Endemic diseases, which are widely accepted in modern livestock farming, pose a significant 
challenge to livestock health, welfare and productivity and often have serious implications 
for public health and food security. While public interest is mostly occupied by epidemic 
diseases such as foot and mouth disease or avian influenza (Otte et al., 2004; Rowe et al., 
2008), endemic diseases cost the United Kingdom's (UK's) livestock industry in excess of 
£600 million per year (Bennett and IJpelaar, 2005). This has driven a rapid increase in the 
exploitation of available data for animal health surveillance (AHS), which presents a 
significant opportunity to monitor populations and to develop new strategies for the control 
of endemic diseases. 
This thesis focuses upon sheep scab, which is the most significant ectoparasite of sheep in 
the UK. Sheep scab presents a substantial welfare and economic problem to the sheep 
industry and historically has been very difficult to control, particularly after the deregulation 
of statutory control programmes in 1992 (French et al., 1999). Importantly, as the first 
confirmed cases of resistance to treatment were reported in 2018 (Doherty et al., 2018), the 




1.1. Animal health surveillance 
1.1.1. Introduction 
Due to the ongoing coronavirus (COVID-19) pandemic, a spotlight has been shone on AHS 
in recent months. The expertise gathered over a number of years through the handling of 
novel animal diseases is being called upon to aid public health and guide the global response 
(Foddai et al., 2020). Whilst a wealth of information is available from the development, 
implementation and constant review of surveillance activities and techniques (Bisdorff et al., 
2017; Department for Environment Food and Rural Affairs [DEFRA], 2011; Scottish 
Government, 2011 and others), AHS, which is used to detect new and emerging diseases and 
monitor the trends of endemic diseases, has only become a field in its own right in the past 
two decades (UK Surveillance Forum [UKSF], 2019). Over this time, many definitions for 
AHS have been proposed. In 2011, at the first International Conference for AHS, a group of 
experts developed a standardised definition as: “The systematic, continuous or repeated, 
measurement, collection, collation, analysis, interpretation and timely dissemination of 
animal health and welfare related data from defined populations… then used to describe 
health hazard occurrence and to contribute to the planning, implementation, and evaluation 
of risk mitigation actions” (Hoinville et al., 2013). Surveillance is therefore distinguished 
from monitoring as it offers feedback to stakeholders and decision-makers, allowing for the 
continued improvement of strategies implemented to control diseases.  
 
1.1.2. Surveillance systems 
Surveillance is delivered through the use of surveillance systems, which comprise of a 
number of components contributing to the "planning, implementation, and evaluation of 
risk-mitigating actions" (Hoinville et al., 2013). Risk-based surveillance systems generate 
information about a particular condition within a set population and subsequently inform the 
overall national surveillance strategy (OIE, 2019). The design of each surveillance system is 
principally dependent on the objective, or set of objectives, which assert the system's role in 
the wider surveillance network. Common surveillance system objectives for livestock 
disease include: the detection of notifiable diseases, detection of new and emerging diseases, 
proving freedom from diseases, and monitoring the risk and trends of endemic diseases 
(Middlemiss et al., 2018). However, further attributes such as the case definition, the target 
population, and the available resources also need to be considered in order to design an 
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effective surveillance system (OIE, 2019). Effective surveillance systems also need to 
operate in a cost-effective manner.  
However, irrespective of the individual surveillance system design, the fundamental 
components of surveillance systems are very similar. Surveillance operates through a 
continuous cycle of collection and collation of data, data analysis, interpretation, 
dissemination and evaluation (Hoinville et al., 2013). 
1.1.2.1. Data collection and collation 
Data collection is the foundation of all surveillance systems, as the quality and relevance of 
the data determines the maximum potential value of the system's outputs. Data should be 
representative of the population studied, minimise bias and ultimately enable the fulfilment 
of the surveillance system's objectives. Selecting a suitable data source therefore requires 
balancing specificity, data quality and representativeness of the population at risk (Barrett, 
2017).  
Two main frameworks exist for the collection of surveillance data: targeted ('active') and 
scanning ('passive'). Targeted surveillance is a scheduled risk-based approach. Due to the 
associated costs of this method, targeted surveillance is reserved for high-risk, notifiable, or 
potentially zoonotic diseases with significant economic or public health implications 
(Middlemiss et al., 2018). As data is purposefully collected, targeted surveillance can 
normally achieve a representative picture of the population at risk and minimises selection 
bias (Gerardo-Giorda et al., 2013). In contrast, scanning surveillance is more commonly used 
where the perceived economic cost is less, such as in the case of endemic diseases (Doherr 
and Audige, 2001). Scanning surveillance is based on the voluntary reporting of cases from 
a variety of sources. In Great Britain (GB) this is predominantly achieved through the 
Veterinary Investigation Diagnosis Analysis (VIDA) database, which is a collection of all 
clinical diagnoses from submissions made to the Animal and Plant Health Agency's 
(APHAs) veterinary investigation centres (VICs), Scotland's Rural College veterinary 
services (SRUC VS) disease surveillance centres (DSCs), and partner post-mortem 
examination providers for livestock and wildlife in GB (APHA, 2019). Scanning 
surveillance represents a cost-effective methodology for monitoring a variety of diseases, 
particularly endemic diseases, but is often subject to much higher levels of selection bias. 
Currently, the sources of data utilised for scanning surveillance are few; however, places 
such as markets, abattoirs, fallen stock centres and private laboratories are showing potential 
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as sources of surveillance data (Barrett, 2017; Küker et al., 2018; McCue and McCoy, 2017 
and others). In recognition of this, the UK's surveillance strategies are changing and 
encouraging the use of additional sources of data to complement and develop a more 
complete picture of endemic diseases (DEFRA, 2011; Scottish Government, 2011; UKSF, 
2019).  
While the quality of the collected data is paramount, these data must also be collated and 
converted into a useable format to facilitate analysis and achieve the aims of the surveillance 
system. For purpose-built databases, such as the VIDA database, the effort required to collate 
data into useable formats is often minimal, which facilitates the direct analysis of data and 
saves time which subsequently leads to greater outputs (Boden et al., 2017; VanderWaal et 
al., 2017). However, if the data were not originally intended for surveillance, they might not 
be formatted in an easily accessible manner. In this case, disparity between case definitions 
from different sources (e.g. through the use of different diagnostic methodologies) and 
suboptimal data management practices make interpretation and integration of these data into 
existing systems difficult and time-consuming (Barrett, 2017; Meidenbauer, 2017). It is 
estimated that, of the time spent on data processing including analysis, over 60% is taken by 
pre-processing time (Sun et al., 2018). As such, data which require considerable pre-
processing must be sufficiently valuable to justify this expense (VanderWaal et al., 2017). 
Also, 'big data' are becoming more prevalent within human and veterinary healthcare fields, 
hence it is likely that existing methods for collection, collation, and analysis will soon be 
insufficient (McCue and McCoy, 2017). Another significant barrier is the lack of 
accessibility to potentially valuable data. Accessibility can be affected by data 
confidentiality requirements, ownership, formatting, and a lack of sufficient resources to best 
utilise these data (Gates et al., 2015; Schneeweiss, 2014). Various attempts have recently 
been made to try and offer a sustainable method to introduce additional complementary data 
for AHS purposes, such as the Rapid Analysis and Detection of Animal-related Risks 
(RADAR). Yet, information on the current operational status of these data sources is difficult 
to identify (Sala, 2016).  
1.1.2.2. Data analysis, interpretation and dissemination of outcomes 
Data analysis allows for the interpretation of the data in reference to the surveillance 
objectives and available resources. The data analysis methodologies applied are often varied 
in order to meet the specific objectives and fulfil the specific needs of stakeholders. Analysis 
methods can include: monitoring the number of cases over time, prevalence calculations, 
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spatial distribution and modelling of disease transmission (Gamado et al., 2017; Jack et al., 
2017; Rodríguez-Prieto et al., 2015).  
Interpretation and dissemination of the results are the end goals of surveillance. There are a 
number of methods through which interpretation and dissemination are guided, which highly 
depend upon the surveillance objectives and the target audience (e.g. policymakers, 
veterinarians, farmers, etc). Current scanning surveillance outputs in the UK include 
quarterly disease updates on relevant endemic diseases, annual reports, and a disease 
dashboard which shows the number of diagnoses made for diseases in sheep, cattle, pigs and 
avian species (APHA, 2019b, 2020a). In general, outputs from surveillance can vary 
considerably. To encourage consistency in the reporting of AHS outcomes, a new set of 
guidelines were developed in 2019, the Animal Health Surveillance Reporting guidelines 
(AHSURED), which aimed to support the effective dissemination and the interpretation of 
AHS by the target audience (e.g. stakeholders and decision-makers) (Comin et al., 2019). 
The AHSURED guidelines were developed as part of the European Union’s (EU) RISKSUR 
(risk-based animal health surveillance systems) project to deliver a comprehensive checklist 
of critical and optional criteria for reporting, based on the objectives of risk-based 
surveillance systems (Comin et al., 2019). 
1.1.2.3. Evaluation of surveillance systems 
The evaluation of surveillance systems, which aims to maintain effectiveness while 
containing costs has recently gained interest, as governments attempt to maximise the 
sustainability of surveillance with limited resources (DEFRA, 2011; Drewe et al., 2012; 
Middlemiss et al., 2018). Evaluation is not yet a routine component of most surveillance 
systems, and evaluations can take many forms. Most evaluations currently performed are 
unstructured and have been developed by the same institutions or organisations which 
perform the surveillance as a form of self-evaluation (Calba et al., 2015). However, two 
frameworks have been recently developed to allow a more standardised process of 
evaluation: the SERVAL (Surveillance Evaluation) framework (Drewe et al., 2015) and the 
RISKSUR EVA tool (Survtool) (Comin et al., 2016). Both of these methods are fairly similar 
in design and aim to ensure that each critical attribute is evaluated and weighted based on 
the objectives of the surveillance system. This ensures any conclusions made from an 
evaluation are not compromised from 'forgetting' critical attributes. In future, it may also be 
possible to employ these strategies to appraise the value of new data sources for their 




1.1.3. Surveillance in practice 
1.1.3.1. International examples 
While the concepts of surveillance and surveillance systems are the same irrespective of 
geographical boundaries, countries adopt different strategies to achieve their specific 
surveillance objectives, dependent on risk assessment and available resources. Across the 
EU in particular, AHS is regarded as an essential activity to maintain public health, animal 
health, and international trade relationships. Therefore, AHS is often publicly funded and 
operated (Häsler et al., 2014). However, this is not the case in Denmark, where AHS became 
privately operated in 2008 as the cost of public surveillance centres outweighed their benefit 
due to the low risk of introducing disease (Scottish Government, 2011). Conversely, the risk 
of introducing new or emerging diseases is much higher in countries, such as the United 
States of America (USA), where international trade is a significant component of agriculture 
(Mourkas et al., 2020), with surveillance needing also to be representative of a much larger 
area. Consequently, the approach to AHS in the USA is managed by different public 
agencies dependent on the disease, with the surveillance of notifiable diseases being 
managed at a federal (national) level, and non-notifiable at a state-level (United States 
Department of Agriculture, 2020).  
 
1.1.3.2. Approach to AHS in GB 
In GB, AHS is publicly subsidised and operated. As previously described in 1.1.2.1, the 
majority of scanning surveillance is conducted through the network of VICs and DSCs 
operated by the APHA and SRUC VS respectively. Diagnoses reached at these centres from 
diagnostic samples and necropsies contribute to the VIDA database, which is used to detect 
new and emerging threats and monitor endemic diseases. However, AHS in GB has been 
under increasing scrutiny over the last decade. In 2011, two key reports for the future of 
AHS in the UK were published. One was released by the DEFRA to evaluate the 2003 
Veterinary Surveillance Strategy (VSS), and the other by the Scottish Government, also 
known as the 'Kinnaird' report, which offered the first independent review of AHS in 
Scotland. The recommendations made in both reports resulted in the restructuring through 
closure of government-operated or subsidised laboratories, and the formation of more 
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centralised hubs for diagnostics aiming to provide more cost-effective surveillance without 
impinging on the representativeness, sensitivity and quality of its outputs (DEFRA, 2011; 
Scottish Government, 2011). The proposal of centre closures created much concern from 
industry, veterinarians and farmers (Veterinary Record, 2014; House of Commons Welsh 
Affairs Committee, 2012). Irrespective of public concerns about the loss of local centres, 
seven VICs in England and Wales were closed in 2013 and 2014, and three new third-party 
post-mortem providers (based at universities) were created. Similarly, as part of the new 
surveillance strategy in Scotland, restructuring of services has also taken place more 
recently. This has resulted in three DSCs centres becoming “Veterinary Surveillance Hubs”, 
the inclusion of a third-party post-mortem provider (University of Glasgow) and all of the 
remaining DSCs providing only post-mortem services, with centralization of all the testing 
in Edinburgh (SRUC, 2019). 
Additionally, both the Kinnaird report and a more recent UK-wide surveillance strategy 
report in 2018, concluded that there is still considerable scope to provide surveillance more 
efficiently. Focus is now shifting to include available information from other existing data 
sources (e.g. private labs, health schemes and abattoirs), with an emphasis on collaboration 
to develop a more representative picture of animal health, particularly for endemic diseases 
(Middlemiss et al., 2018; Scottish Government, 2011). However, access to such data for 
surveillance has been historically challenging, mainly due to privacy concerns, lack of 
standardisation (Drewe et al., 2014), and the associated labour requirements to produce 
outputs from this data. Furthermore, despite considerable efforts to create a robust 
surveillance network, it is likely that AHS in the UK will undergo further significant changes 
with Brexit, as many policies adopted EU guidelines. In addition, much funding for 
agriculture currently emanates from EU funds, such as the EU Common Agricultural Policy 
(European Commission, 2020). A scenario planning workshop conducted in 2017 which 
considered 5 potential situations post-Brexit, highlighted the need to create a more resilient 
surveillance network amongst such uncertainty (Boden et al., 2017). Based on these future 
considerations, the importance of AHS against the current constraints has highlighted the 
importance of critically evaluating our existing systems, of becoming more proactive in 
identifying new data sources and in developing more sustainable and cost-effective solutions 




1.2. Sheep scab 
1.2.1. Introduction 
Sheep scab, caused by the non-burrowing Psoroptes ovis mite (Kirkwood, 1986), is one of 
the oldest yet most important ectoparasitic disease of sheep (Cato and Dalby, 1998; 
Nieuwhof and Bishop, 2005). The P.ovis mite is an obligate parasite which abrades the skin 
of the sheep. Antigens produced by the mite initiate the host's hypersensitivity response and 
simulate the release of serous exudate at the site of the abrasion. The mites feed on the 
exudate, reproduce, and continue in a feedback loop of abrasion and exudate production 
which causes skin lesions to form across the body of the sheep (Figure 1.1). Sheep scab 
typically has a long subclinical phase which can last several weeks even in naïve animals 
(Bates, 2009; van den Broek and Huntley, 2003). The complete lifecycle of the P.ovis mite 
takes between 11-19 days dependent on conditions (van den Broek and Huntley, 2003): adult 
females can live between 11-42 days, depositing 1-6 eggs per day for up to 29 days, and thus 
after the first 10 days following infestation the number of mites doubles every 6.3 days (van 
den Broek and Huntley, 2003). In the clinical phase of infestation, sheep become extremely 
pruritic and engage in self-mutilating behaviour (Berriatua et al., 2001; Corke and Broom, 
1999), with prolonged infestations causing hypoproteinaemia from albumin loss, resulting 
in ill-thrift and emaciation (Sargison and Busin, 2014).  
Figure 1.1: Sheep with a severe case of sheep scab, with wool loss and extensive 






Sheep scab is transmitted through both direct and indirect contact. Direct contact 
transmission occurs at close proximities, when an infected sheep comes into contact with a 
naïve sheep (Berriatua et al., 1999). As such, housing sheep over winter or during lambing 
and during management activities can particularly expedite the natural transmission 
dynamics (Kirkwood, 1986). Despite being an obligate parasite, the P.ovis mite can survive 
for almost four weeks off the host and be infective for up to two weeks, dependent on the 
ambient temperature and humidity (van den Broek and Huntley, 2003). Therefore, 
transmission can also occur from the environment, such as from fence posts or handling 
facilities (Berriatua et al., 1999). For this reason, treated sheep should not be reintroduced 
onto infected land, where transmission will occur again, which might prove very difficult 
for some farming systems. Consequently, sheep scab control becomes particularly difficult 
in some areas, especially for holdings which rely on common grazing (Rose et al., 2009). 
 
1.2.2.2. Prevalence 
In 1992, the last year of the mandatory dipping programme, less than 100 sheep scab cases 
were recorded (French et al., 1999). However, over the following years, the number of cases 
spiked, exceeding 7,000 outbreaks in 2004 (Bisdorff et al., 2006). As a result, sheep scab is 
now considered endemic in GB (Sargison et al., 2007). At present, the national prevalence 
of sheep scab in GB is estimated to be around 9% (Bisdorff et al., 2006; Rose et al., 2009), 
however significant regional variation has been shown. From a number of surveys and 
interviews, Wales has been estimated to have the highest prevalence of sheep scab in GB, 
between 16% and 36% (Chivers et al., 2018; Cross et al., 2010; Rose et al., 2009). Other 
areas with a high prevalence of sheep scab infestations include the north of England, south 
west England and Scotland (French et al., 1999). The significant variation in prevalence per 
region highlights the importance of obtaining an accurate picture of the distribution of sheep 
scab in a particular area, also called "hotspot", as well as its change over time. Interestingly, 
85% of the farms that reported a sheep scab outbreak, as part of a survey conducted by Rose 
& Wall (2012) during 2007/2008, had already experienced a previous outbreak, suggesting 
that flocks might not be managing to fully control the disease on their premises, leading to 
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repeated outbreaks. On the contrary, almost 80% of farms in Wales which did not have a 
sheep scab outbreak, had not experienced one in the last 10 years either (Chivers et al., 2018). 
In addition to exhibiting a strong regional variation in prevalence, sheep scab is widely 
considered a seasonal disease, with the majority of infestations occurring in the winter 
months. This seasonality is thought to be influenced by the climate, with improved off-host 
survival in the lower temperatures of winter than in summer (Smith et al., 1999). For their 
continued survival in suboptimal circumstances, it has been suggested mites seek "cryptic 
sites" such as skin folds and the ear canals where they remain asymptomatic over summer 
(Nisbet, 2011). However, this seasonality might also be related to a number of management 
practices, like the traditional summer shearing to reduce the fleece length (French et al., 
1999). Hill sheep are traditionally gathered and handled in the summer months for 
prophylactic application of acaricides and anthelmintics, and the mandatory dipping also 
occurs in the summer months, the residual effect of which would suppress infestations for 
up to two months (French et al., 1999). 
 
1.2.3. Diagnosis & treatment 
1.2.3.1. Diagnosis 
The diagnosis of sheep scab is commonly confirmed through a skin scraping. This involves 
taking skin samples for microscopic examination from lesion sites using a scalpel blade. 
Until recently, skin scrapings were the only diagnostic option. However, in 2017, a new 
sheep scab enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to 
the sheep scab-specific allergen Pso o 2 using blood samples was commercialised (Burgess 
et al., 2012; Nunn et al., 2011). The sheep scab ELISA, developed at Moredun Research 
Institute (MRI), offers a test with a high sensitivity and specificity – 98.2% and 96.5% 
respectively (Hamer et al., 2019) – which can diagnose subclinical disease as early as 2 
weeks after infestation, before clinical signs develop (Burgess et al., 2012). Furthermore, the 
sheep scab ELISA is designed to monitor presence of the parasite at a flock level, which 
could be particularly instrumental for decreasing reliance on the prophylactic use of 
acaricidal products, a priority since the first case of resistance to one of the commonly used 




There are only two licensed products for the treatment of sheep scab: organophosphate (OP) 
plunge dips and injectable macrocyclic lactones (MLs). OPs are very effectual, but their 
main limitations are the structural infrastructure required and the health risks to the operators 
(Blain, 2001). Dip removal and disposal can also prove problematic and as a consequence 
OPs have fallen out of use in favour to the more convenient injectable MLs. In a recent 
survey, over 95% of farmers relied on MLs to treat clinical sheep scab outbreaks, with only 
15% using OP dips (Chivers et al., 2018). MLs offer a more convenient solution for the 
control of sheep scab as they can be administered to sheep of all ages and do not require a 
dedicated infrastructure for delivery. They are also effective against nematodes which 
increases their attractiveness to use, but this also increases the selection pressure by 
increasing their repeated use over time.  
Unfortunately, with limited treatment options for sheep scab and the widespread use of MLs, 
it is not surprising that the first case of resistance to MLs was confirmed in 2018 (Doherty 
et al., 2018; Sturgess-Osborne et al., 2019). This raises much uncertainty about the future 
treatment options for sheep scab, especially if reliance on MLs cannot be reduced. Resistance 
to the MLs will shift pressure onto the OPs, for which resistance would likely develop too 
after the withdrawal of other treatment products (such as the synthetic pyrethroids) from the 
market.  
 
1.2.4. Economic impact 
In 2005, it was estimated that sheep scab costs the sheep industry approximately £8.3 million 
per year (Nieuwhof and Bishop, 2005), with £0.8 million due to productivity losses and the 
remainder from treatment costs. This estimate is now regarded as low, not accounting for 
labour costs, the cost of the subclinical phase, or ineffective treatments (including 
antiparasitic resistance) (Nixon et al., 2017). In addition to the direct cost of treatment, 
infected animals have also been shown to experience a decreased lambing percentage, low 
lamb birthweight, increase in lamb mortality, and increase in barren rate (Nunn et al., 2011; 
Scott et al., 2007). More recent estimates show that sheep scab costs £40.84 per ewe in 
lowland flocks, and £35.12 in upland flocks (Nixon et al., 2017). These figures represent a 
substantial proportion of the sheep's economic value, which would significantly reduce any 
margin for profit (Harvey and Scott, 2020). Indirectly, sheep scab also affects other 
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industries such as the wool and leather. As a results of sheep scab, unusable sheep pelts are 
estimated to cost the leather industry in excess of £15 million per year (Coles, 1998). 
1.2.5. Control of sheep scab 
1.2.5.1. International examples 
Sheep scab has been reported in 149 countries (Kirkwood, 1986); however, successful 
eradication has also been achieved on a number of occasions with different methods. In New 
Zealand, sheep scab was successfully eradicated in 1985 (ADAS, 2008). This was led by the 
public sector, with eradication achieved through targeted surveillance and legislation 
introduced in 1849 (Davidson, 2002). At this time, toxic but effective dips containing 
arsenic, very different to today's compounds, were used for compulsory dipping, which 
steadily decreased the prevalence. When the disease was brought to manageable levels, the 
localised disease clusters were tackled through slaughter of affected flocks and stray sheep 
(Davidson, 2002). Similar techniques for eradication were also applied in Australia, where 
sheep scab was eliminated in 1984, a year before New Zealand (Animal Health and Welfare 
Wales, 2018). Notably, eradication has also been achieved in the USA and Canada, in 1973 
and 1924 respectively (ADAS, 2008). In countries where eradication has been successful, 
reintroduction is always a significant risk. To prevent this, strict biosecurity protocols must 
be followed, complemented by an effective and timely surveillance system to quickly 
identify and prevent the spread of outbreaks. Unfortunately, in many countries, like Sweden, 
Norway and Denmark, eradication was achieved across the late 19th to mid-20th centuries 
only to be reintroduced in the 1970s (Kirkwood, 1986).  
 
1.2.5.2. Past control measures in Great Britain 
Sheep scab has been a well-known presence in GB for centuries, and numerous attempts at 
control have been made over the years. The first legislation for sheep scab in GB dates back 
to as early as 949AD, when King Hywel Dda of Wales banned the sale of 'scabby' sheep in 
the winter months and keeping sheep on land where scabby sheep had resided in the past 7 
years (ADAS, 2008).  
The first period of notifiable status in GB was introduced in 1869 (Watson, 1976), but did 
not mandate the treatment or isolation of infected animals and was not sufficient for control. 
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At the time, many sheep were also being imported to GB from Ireland and the Americas, 
which only compounded the problem (Page, 1969). Then, the introduction of the Sheep Scab 
Order (1898) meant veterinarians were required to diagnose the reported cases of sheep scab, 
and thus the number of cases per year dropped from 2,514 to 1,379. But it was not until the 
Sheep Scab Orders of 1903, 1905 and 1907, that the treatment of sheep scab was made 
compulsory, through a regulated (sheep had to be dipped for 30 seconds) and compulsory 
annual dipping programme (Page, 1969). These treatments, however, were not fully 
effective, so double-dipping (two weeks apart) was introduced in 1914. This was 
significantly more effective, and the number of cases reduced drastically to 226 per year. 
After some variation in the number of outbreaks seen during the First World War, the 
dipping interval was increased from 30 to 60 seconds, to reach mites that resided in cryptic 
sites (Kirkwood, 1986). Despite these efforts, sheep scab was still seemingly impossible to 
eradicate. However, in 1948 the introduction of new formulation with a longer residual 
effect, the organochlorines, made a single dip for a minimum of 60 seconds more effective, 
and elimination in GB was achieved in 1952 (Kirkwood, 1986).  
Mandatory dipping was phased out after elimination, and the country remained free from 
sheep scab for 21 years. However, unfortunately, in 1973 sheep scab was reintroduced. It 
was first identified on a farm in Lancashire and thought to have been reintroduced from 
animal imports from Ireland (Kirkwood, 1986). Localised dipping programmes were 
introduced to control its spread, but these were unsuccessful and led to the reintroduction of 
a national mandatory autumn double-dip in 1976 (Kirkwood, 1986; van den Broek and 
Huntley, 2003), which was implemented under the Sheep Scab Order (1977) (Henderson, 
1990). 
Mandatory dipping continued across different formats, with summer dipping also being 
introduced nationally in 1982 (Kirkwood, 1985). The number of cases per year during this 
time fluctuated but largely remained around 100 per year. The lowest number of outbreaks 
was 36 in 1988, but subsequently increased (ADAS, 2008). Sheep scab was ultimately 
deregulated in 1992 as eradication was deemed unfeasible and expensive (ADAS, 2008). As 
such cases spiked significantly from less than 100 per year prior to 1992, to an estimated 
7,000 by 2003 (Bisdorff et al., 2006).  
In contrast to the rest of GB, the Shetland Isles are free from sheep scab. A small-scale 
outbreak was identified in 1993, but all sheep within 10 miles were then dipped to 
successfully prevent its spread. All sheep are now injected with Dectomax, a ML, as part of 
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the quarantine procedures when imported to the Isles (Harmsworth, 1997). Shetland also has 
its own legislation in place, the Sheep Scab (Shetland Isles) Order 2003. This allows the 
council to inspect and test for sheep scab mites upon import, and a minimum of a 48-hour 
quarantine period for imported animals (Scottish Government, 2003). 
1.2.5.3. Current control measures in GB 
The legislation currently in place in England and Wales is the Sheep Scab Order (1997), 
which mandates the treatment and bans the movement of visibly affected sheep (Minister of 
Agriculture, Fisheries and Food, 1997). By contrast, in Scotland (with the exception of the 
Shetland Isles) sheep scab was reinstated as a notifiable disease in 2010 through the Sheep 
Scab (Scotland) Order (2010) (The Scottish Government, 2010). However, despite these 
current legislative measures, sheep scab remains a significant welfare and economic problem 
to the industry. Historically, many control efforts were effective, but under the current 
circumstances and its endemic status, achieving control of sheep scab in GB is likely to be 
challenging. Therefore, the development of future control measures needs to exploit all 
sources of data to provide solid and evidence-based basis towards a cost-efficient and 




1.3.  Aims 
Using sheep scab as a model, this research project aims to enhance the use of existing 
surveillance data and evaluate new data sources to guide future control strategies for sheep 
scab. This will be achieved through the collection, collation and analysis of two data sources: 
the existing scanning surveillance VIDA database, and the data from the sheep scab ELISA. 
More specifically, this project has the following objectives: 
• To use the existing scanning surveillance data to identify current trends and 
geographical "hotspots" for the target of future control measures (Chapter 2). 
• To use the existing scanning surveillance data to investigate the impact of national 
targeted disease control initiatives and inform on their use as part of future control 
measures (Chapter 2). 
• To provide a new usable source of data through digitisation of all data from the sheep 
scab ELISA (Chapter 3). 
• To provide information on the current use and uptake of the sheep scab ELISA and 
evaluate the risk associated with certain management practices (Chapter 3). 
• To investigate the potential value of the sheep scab ELISA data as a complementary 
source of scanning surveillance (Chapter 3). 
This research also represents the first work package of a larger multidisciplinary project: 
Department for Environment, Food and Rural Affairs (DEFRA) – Veterinary Medicines 
Directorate (VMD) Lot 2 Antiparasitic Resistance: Sheep Scab, which will provide the 
foundation for further analysis and modelling of a range of disease control scenarios, for the 
ultimate goal to identify the optimum pathway towards better targeted and coordinated 




2. Exploiting the use of existing scanning 
surveillance data for sheep scab 
2.1. Introduction 
The development of sustainable and cost-effective strategies is paramount to facilitate the 
control of endemic disease. Currently, surveillance of endemic diseases in GB, including 
sheep scab, is predominantly achieved through the VIDA database (as described in 1.1.2.1). 
However, the possibility of further exploiting the use of this data is increasingly recognised, 
hence the government is promoting sharing of this data to increase output and encourage a 
more cost-effective approach to the control of endemic diseases (Middlemiss et al., 2018). 
In the case of sheep scab, the first steps towards developing effective control strategies is to 
improve the understanding of its spatial and temporal trends. As sheep scab has previously 
shown a high regional variation in prevalence (French et al., 1999; Rose et al., 2009), areas 
with a high disease burden also need to be identified to focus efforts for disease control. An 
important concept for monitoring the true prevalence of a disease also includes knowing the 
proportion of disease within the population at risk. However, with diagnostic datasets such 
as the VIDA database, an appropriate denominator for this data is often not available, which 
can be a limitation for its interpretation (Tongue et al., 2020).  
There are often many approaches tried in an attempt to control endemic diseases due to their 
complexity. For sheep scab, since the removal of the statutory control programme in 1992 
(French et al., 1999), a number of targeted disease control initiatives have been adopted to 
improve the awareness and knowledge of the disease and contribute towards control. These 
initiatives are normally industry or government funded, run for a limited period of time, and 
are working towards a set goal such as increasing awareness, providing education about the 
disease, and advice on treatment options (Department of Agriculture Food and the Marine, 
2017). Yet, such initiatives are often expensive, time consuming and difficult to coordinate. 
Therefore, the impact of these initiatives requires to be evaluated, which could provide 
guidance to their effectiveness as a tool for sustainable and cost-effective control. 
To aid in the evaluation of impact and guide future initiatives, temporal aberration detection 
algorithms (TADAs) could be utilised. TADAs are conventionally used as bio-surveillance 
tools to detect outbreaks of pathogens in hospital settings (Yuan et al., 2019). The application 
of a TADA can identify a statistically significant increase in the number of cases over time, 
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from a predetermined background level of disease. When a statistically significant increase 
occurs, an alarm is raised which indicates a potential outbreak (Höhle and Mazick, 2010; 
Salmon et al., 2016; Zhou et al., 2015). These systems can offer a real-time evaluation of 
disease, which makes them a very important tool within public health. However, 
increasingly, their application for other purposes is also being acknowledged, particularly 
within veterinary medicine (Tongue et al., 2020).  
This chapter, therefore, aims to use the VIDA database to identify current trends and 
geographical "hotspots" for sheep scab. Furthermore, it aims to explore the potential utility 
of the TADAs to retrospectively investigate the impact of previous national targeted disease 




2.2. Material and methods 
2.2.1. Data collection and description 
2.2.1.1. VIDA data collection 
As described in 1.1.2.1, the VIDA database records all diagnostic submissions made to the 
APHA's VICs, SRUC VS DSCs, and partner post-mortem providers where a final diagnosis 
has been reached by one of the Veterinary Investigation Officers (VIO) working in the 
centre. Samples are routinely submitted on a voluntary basis from referring private 
veterinarians and farmers for diagnostic investigations. The submissions can include one or 
multiple samples and the sample material can range from blood, milk, tissue or faecal 
samples to whole carcasses. When a diagnosis (or multiple diagnoses) is reached, it is 
assigned one (or multiple) VIDA codes by a VIO. VIDA codes are given to submissions 
where the diagnosis meets pre-determined and defined criteria. 
For the diagnosis of sheep scab, the VIDA database includes only diagnoses made at the 
APHA and SRUC VS laboratories through a standardised and United Kingdom 
Accreditation Service (UKAS) accredited skin scrape test, to directly identify the Psoroptes 
ovis mites from skin scrape samples through microscopy. Skin scrape samples are taken 
using a scalpel blade on the outside edge of a lesion site by a private veterinarian. At the 
laboratory, skin scrapes are examined under low power microscopy (X100) by the veterinary 
investigation officer (VIO) to determine the presence of mites. If no mites are detected from 
the initial microscopy a digest is performed. The digest involves boiling the sample in a 
potassium hydroxide solution to dissolve any hair and lesion material in the sample, to allow 
for easier visualisation of mites that may have been trapped in lesion crusts. Once the digest 
has been performed the sample is again examined by low power microscopy (Ministry of 
Agriculture Fisheries and Food, 1971). If a positive sheep scab diagnosis is reached for at 
least one sample within a submission, the submission is assigned the VIDA code '390'. 
For the purposes of this study all submissions that were assigned the code '390' (herein 
referred to as 'positive scrapes') were extracted from the VIDA database, together with their 
submission date and a regional geolocator, from January 1995 to September 2019 inclusive. 
However, due to incompleteness of the data in early years, the foot-and-mouth disease 
epidemic in 2001, and the subsequent restocking of livestock in 2002 as a result of the 
outbreak, only data from January 2003 onwards were included in the analysis. 
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2.2.1.2. Denominator data 
To determine an appropriate denominator for the analysis of positive scrapes, four potential 
datasets were also obtained from the VIDA database. The individual descriptions of each 
datasets are listed in Table 2.1. All datasets were extracted as a total count per year for the 
16-year study period (2003 to 2018). 
Table 2.1: Description of the datasets available as potential denominators extracted from 
the VIDA database 
Name of dataset Description 
Total diagnostic 
submissions 
Count of all diagnostic ovine submissions submitted to the 
APHA, SRUC VS and partner post-mortem providers. Samples 
could contain any type of sample material (e.g. carcass, blood, 
faeces etc.) from an ovine. Where multiple samples (of any 
type) were included within one submission, this was regarded 
as a single submission.  
Skin submissions Count of all diagnostic ovine submissions where the main 
presenting sign on the submission form was recorded as “skin” 
by the submitting private veterinarian. 
Scheduled scrapes Count of the number of scheduled (made by the VIO) skin 
scrape tests for ovines. The tests included: the APHA's test 
code 'TC81' for an ectoparasite examination and the SRUC test 
codes "MicrSk" for microscopic examination of the skin or 
hair, "Shscab" for sheep scab examination, and "Skpara" for 
microscopic examination for lice or mites. Where multiple skin 
scrapes were scheduled for one submission, this was recorded 
as 1 scheduled scrape. 
Scrape submissions Count of all skin scraping submissions (made by the private 
veterinarian) of ovines.  
 
2.2.1.3. Sheep scab initiatives  
To identify all the targeted sheep scab disease control initiatives which took place during the 
study period across GB and collect details of each, a variety of sources were consulted. 
Primarily, information regarding the initiatives derived from publicly available sources such 
as peer-reviewed literature, government and industry reports. Besides this, industry and 
government experts were also consulted to capture initiatives where there was no, or 
insufficient, information otherwise available. National initiatives, i.e. those which took place 
in one or more of the three countries in GB, were selected as they were designed to reach a 
larger portion of the population at risk, featured well-defined start and end dates, and had a 
higher proportion of information available from primary sources. All the initiatives 
identified and collated across all countries were categorised into a 'type' which pertained to 
the planned actions of the initiative to allow grouping of initiatives. These categories were: 
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'free testing', where the cost of skin scraping tests was waived or subsidised; 'knowledge 
transfer & skills training', where education was provided through workshops and training 
sessions; 'knowledge transfer & free testing', where education was provided, coupled with 
free skin scraping tests; and 'legislation', where a new legislation was introduced beyond the 
scope of the current Sheep Scab Order (1997). 
 
2.2.2. Data analysis 
All data analyses and visualisations, unless otherwise stated, were performed in R version 
3.5.1 and RStudio.  
2.2.2.1. Spatial analysis 
The data from positive scrapes were provided with a regional geolocator, approximate to 
county-level, which was used to descriptively assess the spatial distribution of sheep scab 
across GB during the study period. The counts were aggregated by region, (i) firstly per year 
for the full study period and then (ii) totalled across all years. The aggregated totals were 
mapped using a shapefile provided by the APHA, including the correct boundaries of the 
regions defined in the dataset. In addition, the location of the DSCs and VICs were 
determined and plotted by extracting longitude and latitude from their postal codes using the 
Office for National Statistics' (ONSs) Postcode Lookup database (Office for National 
Statistics, 2019a).  
2.2.2.2. Temporal analysis 
The total number of positive scrapes were plotted by year to assess the temporal pattern of 
sheep scab across GB during the study period. A Poisson regression was then applied to test 
the effect of year on the number of positive scrapes. The combination of this analysis with 
the provided regional geolocator was used to plot the positive scrapes by year and country 
to assess the temporal difference among England, Scotland and Wales. Subsequently, a 
Pearson's Chi-squared test was performed to ascertain whether the difference was 
significant. The count of positive scrapes was also grouped by month across the whole study 
period to investigate the seasonal pattern of sheep scab.  
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2.2.2.3. Denominator analysis 
The total counts of the four datasets were directly compared to the number of positive scrapes 
for the 16-year study period (2003 to 2018). Then, the selected potential denominators were 
visualised as counts per year compared to the number of positive scrapes, to provide a 
percentage and act as denominator(s) for the interpretation of the VIDA positive scrapes. 
 
2.2.3. Aberration detection 
A temporal aberration detection algorithm (TADA) was applied retrospectively to measure 
the impact of disease control initiatives on the number of positive scrapes recorded in the 
VIDA database. The original Farrington algorithm, which uses an over-dispersed quasi-
Poisson regression-based method for weekly aberration detection, was applied to this dataset 
due to its suitability for count data, ability to account for seasonality, and good sensitivity 
using the 'surveillance' package in R (Farrington et al., 1996; Höhle and Mazick, 2010; Zhou 
et al., 2015). To use the TADA, firstly a period free from suspected aberrations (i.e. a 
baseline period) is required to train the model. The quality and length of this baseline period 
is crucial, determining the sensitivity of the model (i.e. its ability to detect true aberrations) 
using a defined significance level (set at α = 0.01). When the TADA is applied to the entire 
dataset, excluding the baseline ('training') period, an alarm is generated if the observed 
number of counts (i.e. positive scrapes) exceeds the upper threshold predicted by the 
algorithm, denoting a significant aberration. 
As the sheep scab initiatives were specific to each country within GB, a separate TADA was 
performed for each country. The Farrington algorithm utilised the number of positive scrapes 
per country, aggregated by week in accordance with the ISO 8601 international standard of 
time and date (International Organization for Standardization, 2004). The weekly aggregates 
were then subsequently visualised as a time series to evaluate the most appropriate baseline 
period, ensuring there were no suspected aberrations or disease control initiatives before the 




2.3.1. VIDA descriptive analysis 
A total of 2,401 positive scrapes were recorded between the 1st January 2003 and 31st 
December 2018. As displayed in Figure 2.1, a significant decrease was observed in the 
annual count of positive scrapes from the beginning of the study period (p < 0.001). The 
maximum recorded number of positive scrapes was in 2004 (n = 277), falling to the lowest 
in 2015 (n = 55). In contrast to the overall decline observed over the study period, the number 
of positive scrapes increased by over 2.5 times from 2017 (n = 68) to 2018 (n = 172). 
 
Of the total count of positive scrapes, 2,310 included a geolocator from which the country 
information could be derived. The annual pattern of positive scrapes per country is displayed 
in Figure 2.2. Overall England, Wales and Scotland presented a similar pattern, with a 
prolonged but fluctuating decline over the study period, with the exemption of a sharp 
increase in counts in Wales in 2018. Wales exhibited consistently higher counts of positive 
scrapes compared to England and Scotland, with the highest count in 2004 (n = 134). The 
only year where the number of positive scrapes was higher in Scotland (n = 29) than in Wales 




(n = 19) was in 2014. In England, the highest count of positive scrapes was also observed in 
2004 (n = 84), and after a consistent decline, the lowest count occurred in 2015 (n = 9). In 
Scotland, highest number of positive scrapes was in 2003 (n = 60), and the lowest in 2017 
(n = 17). Finally, a statistically significant difference was shown between the total number 
of positive scrapes of the three countries (p < 0.001). 
  
 
The overall distribution of positive scrapes by month shown in Figure 2.3 displays a strong 
seasonal pattern. The highest number of positive scrapes occurred in January (n = 475). 
Higher counts were observed across autumn and winter, specifically between October and 
March (mean = 300 positive scrapes per month). Lower counts numbers were observed in 
the summer months from April to September (mean = 100 positive scrapes per month), with 
the lowest occurring in June (n = 62). This seasonal pattern of positive scrapes was also 
similar between the three countries, with the exception of England in September which 
displayed the lowest number of positive scrapes in a single month (n = 12) (Appendix 1). 
Furthermore, for two months, May 2013 and July 2018, no positive scrapes were reported 
(Appendix 2). 








2.3.2. Denominator selection 
Of the four datasets analysed, 'total diagnostic submissions' had the highest count (n = 
146,199), and (as shown in Table 2.2) the total number of positive scrapes (n = 2,401) 
represented, therefore, a very small proportion of this potential denominator. As a result, 
'total diagnostic submissions' was excluded from consideration as a potential denominator. 
 
Table 2.2: The total count of submissions included for each dataset, and the percentage of 
the total number of positive scrapes (n = 2,401) for the study period (2003-2018). 
Dataset Total count Total positive scrapes as a 
percentage of the total 
denominator count (%) 
Figure 2.3: Monthly aggregate of positive scrapes (n = 






Skin submissions 8,146 29.5% 





The datasets 'skin submissions', 'scheduled scrapes' and 'scrape submissions' all displayed 
similar annual trends (Figure 2.4). Despite having a similar trend to the count of positive 
scrapes, the number of 'scrape submissions' was consistently below that of the positive 
scrapes, and consequently the total number of positive scrapes represented 124.3% of these 
submissions (Table 2.2).This implies that many cases of sheep scab were diagnosed from 
submissions other than skin scrapings (e.g. carcasses). Based on this, 'scrape submissions' 
was also excluded as a potential denominator, as it did not account for sheep scab diagnoses 
made from other sample types.  
 
Figure 2.4: Annual trend of three potential denominators, overlaid by the yearly totals 
of positive scrapes (black line). A) Skin submissions (n = 8,148). B) Scheduled scrapes 
(n = 5,171). C) Scrape submissions (n = 1,932). 
 A)                B)                C) 
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2.3.3. Descriptive spatial analysis 
In total, 2,310 of the 2,401 positive scrapes (96.2%) included a regional geolocator which 
allowed them to be categorised into 69 defined geographical regions across GB (7 in Wales, 
14 in Scotland, and 48 in England). At the beginning of the study period, 25 VICs were in 
operation across GB. As of the end of 2018, 18 of these were still operational. All closures 
during the study period took place in England, with one closure in 2013, and the other 6 in 
2014 (Figure 2.5). 
Figure 2.5 displays the total counts across the full study period (2003-2018), overlaid by the 
VIC locations which have been in operation since the start of the study period, and their 
operational status at the end of the study period in 2018. The number of cases across GB was 
unevenly distributed across the study period, with 52.4% of cases originating from Wales, 
25.8% from Scotland and 21.8% from England. The county with the highest number of 
positive scrapes across all years was Ceredigion, representing 16.4% of the total diagnoses 
(Table 2.3). Ceredigion also represented the focal point within Wales, with the adjacent 
North West Wales, Powys and Carmarthenshire also displaying high counts as seen in Table 
2.3. Of the 7 Welsh regions, 5 were within the 10 regions with the highest total positive 
scrapes, with the other 5 regions all within Scotland (Table 2.3). In England, the region with 
the most positive scrapes was Devon with 52. Regions with 0 positive scrapes within the 
study period were Berkshire, Cambridgeshire, East Riding & North Lincolnshire, 





From the study period, 4 years (2003, 2007, 2013 and 2018) were selected to represent the 
changes in the spatial distribution of the count of positive scrapes (Figure 2.6). The count of 
positive scrapes in 2003 (Figure 2.6 A) saw a maximum of 26 positive scrapes in one region, 
North West Wales. Overall, the highest number of positive scrapes was seen across the west 
of Wales, which included Ceredigion, Carmarthenshire and North West Wales (n = 20-26) 
and in Tayside, Scotland (n = 11). In 2007 (Figure 2.6 B), Ceredigion observed the highest 
number of positive scrapes seen in one county across all years, with a total of 47. This peak 
Figure 2.5: Spatial distribution of the total VIDA positive sheep 
scab submissions from 2003-2018. Points overlaying this represent 
the disease surveillance centres and veterinary investigation 
centres which have been open during the study period. The shape of 
the point, a circle or triangle, represents the centre's current status: 
closed or open respectively. 
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in Ceredigion also aligned with a more generalised increase in positive scrapes within Wales 
during 2007 (mean of 17.8 positive scrapes per region). The count in England and Scotland 
remained low (n = <14). In 2013 (Figure 2.6 C), a decrease in the number of positive scrapes 
occurred across the country, with a maximum of 11 positive scrapes in any region, observed 
in Ceredigion. In 2018, the low counts (n = <7) remained across England and Scotland 









Figure 2.6: Spatial distribution of VIDA positive scrapes in Great Britain for four key 
years in the 2003-2018 study period:  A) 2003, B) 2007, C) 2013 and D) 2018. 
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Table 2.3: The ten regions with the highest totals of positive scrapes across 2003-2018. 
Region Country Total 
Ceredigion Wales 378 
North West Wales Wales 279 
Carmarthenshire Wales 189 
Powys Wales 188 
Highlands Scotland 121 
Dumfries & Galloway Scotland 120 
Tayside Scotland 103 
Scottish Borders Scotland 82 
North Eastern Scotland Scotland 75 





2.3.4. Sheep scab initiatives 
Within the study period, 11 targeted sheep scab disease control initiatives, as described in 
Table 2.4, took place between 2003 and 2018 across GB: 4 in Wales, 3 in England and 4 in 
Scotland.  
Wales 
In Wales, all four initiatives were categorised as 'free testing’. The details of the first APHA 
free testing initiative (operating from 1st December 2003 to 28th February 2004), the Hybu 
Cig Cymru (HCC)/Meat Promotion Wales and sheep scab ELISA validation were all 
similarly sourced from personal correspondence (Table 2.4). As such, no official report was 
available on the results of these initiatives. However, a report was available for the second 
period of APHA free testing (from 20th December 2017 to 31st March 2018) (APHA, 2018a), 
which outlined the intended aims and results of this period of free testing (Table 2.4). 
England 
England shared two of its three initiatives with Wales: the APHA free testing (from 1st 
December 2003 to 28th February 2004), and the sheep scab ELISA validation free testing 
(Figure 2.7). The third, instead, was an industry-led 'knowledge transfer & skills training' 
initiative named "Stamp out Scab", which operated for 15 months. The details of the two 
initiatives shared with Wales were similarly obtained from personal correspondence (Table 
2.4). Information about the aims and workshops delivered to veterinarians and Registered 
Animal Medicines Advisors (RAMAs) as part of the "Stamp out Scab" campaign was 
obtained from the advertising material and previous literature (Table 2.4). 
Scotland 
Uniquely, Scotland offered its initiatives continuously throughout the study period (Figure 
2.7). For the first 8 months the SRUC offered free diagnostic tests for sheep scab, similar to 
the APHA free testing initiatives. Then, the Scottish Sheep Scab Initiative (SSSI) was 
introduced as a result of industry pressure to control sheep scab. This was led by industry 
and government, offering advice on best practice coupled with free testing to increase 
awareness of sheep scab (Table 2.4). After the SSSI ended, the SRUC free testing resumed 
and a working group was formed to pave the way towards developing legislation, the Sheep 
Scab (Scotland) Order 2010. This reintroduced sheep scab as a notifiable disease in Scotland, 




Table 2.4: Description of the targeted national sheep scab disease control initiatives that occurred between the 1st January 2003 and 31st December 
2018 across GB. ADAS = Agricultural Development Advisory Service, APHA = Animal and Plant Health Agency, AHDB = Agriculture and Horticulture 
Development Board, HCC = Hybu Cig Cymru / Meat Promotion Wales, RAMA = Registered Animal Medicines Advisor, RDPE = Rural Development 




Start Date End Date Initiative Type Description 
Wales     
APHA 1st December 
2003 
28th February 2004 Free testing Period of free skin scrape testing funded and operated by 





1st January 2007 28th February 2007 Free testing Period of free skin scrape testing funded by HCC, an 





1st April 2015 1st September 2015 Free testing Period of free testing initiated by the APHA inviting the 
submission of a skin scraping and blood sample for the 
validation of the sheep scab ELISA. (S Mitchell, personal 
communication). 
APHA 20th December 
2017 
31st March 2018 Free testing Period of free testing funded by the Welsh Government and 
operated by the APHA, after the first reported cases of 
resistance to macrocyclic lactones were identified (Doherty 
et al., 2018).  
England     
APHA 1st December 
2003 
28th February 2004 Free testing Period of free skin scrape testing funded and operated by 
the APHA (S Mitchell, personal communication). 
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1As of September 2020
Stamp out Scab 1st January 2013 31st March 2014 Knowledge transfer & 
skills training 
Initiative aimed at knowledge transfer (facilitated by 
RAMAs for dissemination to clients) and skills training 
(sessions provided by ADAS veterinarians), instigated by 
the AHDB and funded through the RDPE (ADAS, 2013; 




1st April 2015 1st September 2015 Free testing Period of free testing initiated by the APHA inviting the 
submission of a skin scraping and blood sample for the 
validation of the sheep scab ELISA. (S Mitchell, personal 
communication). 
Scotland     
SRUC VS 1st January 2003 10th September 2003 Free testing Period of free skin scrape testing funded and operated by 





31st December 2006 Knowledge transfer & free 
testing 
A largely industry-led, 3-year long initiative launched at 
Kelso ram sales (Hosie, 2003) initiated by NFU Scotland 
towards increasing awareness of sheep scab and promoting 
best practice in disease control through the provision of 
information (ADAS, 2008). 
SRUC VS 1st January 2007 16th December 2010 Free testing Period of free skin scrape testing funded and operated by 






Ongoing1 Legislation Mandated the notification of holdings with or suspected to 






Figure 2.7: Timeline of the targeted sheep scab disease control initiatives from 2003-2018 across GB, which includes free testing (green), knowledge 




2.3.5. Aberration detection 
The TADA was applied separately for each country due to the devolved nature of animal 
health in GB, which has been shown to apply to sheep scab through the largely devolved 
initiatives (Figure 2.7), and differences in counts and trends of each country (Figure 2.2). 
The baseline period used for England ran from week 1 of 2006 to week 52 of 2009. A later 
starting reference period was used due to high counts being observed at the beginning of the 
study period compared with later years as seen in Appendix 3A, and also taking into 
consideration the APHA period of free testing from 1st December 2003 to the 28th February 
2004 (Figure 2.7). Therefore, the study period analysed by the TADA was from week 1 of 
2010 to week 52 of 2018. The TADA raised one alarm during the study period (Figure 2.8). 
The alarm was raised in week 39 of 2010 (week beginning 27th September), when 4 positive 
scrapes were diagnosed, exceeding the upper boundary of 3.45 predicted positive scrapes 
(Table 2.5) and also representing the highest count of the weekly time-series for England. 
This alarm occurred outside the time period of any of the regional initiatives (Figure 2.7). 
For Wales, the period of APHA free testing was also excluded from the baseline period, as 
it was for England. Due to a higher number of counts per week in Wales opposed to England 
and Scotland (Appendix 3), convergence of the model was achieved with a shorter baseline 
period of 2.5 years, from week 27 of 2004 to the end of 2006. Therefore, the TADA was 
applied across week 1 of 2007 to the end of 2018. This allowed the TADA to evaluate three 
of the four initiatives that occurred across the study period.  
The TADA for Wales raised 15 alarms (Figure 2.9) from 2017 to 2018. In total, 11 of the 15 
alarms (73.3%) occurred from December 2017 to March 2018, falling within the APHA free 
testing initiative period. The other four alarms did not align with any other known national 
initiatives. The counts observed on weeks with alarms, compared to the upper threshold 
produced by the model are displayed in Table 2.5. The highest number of positive scrapes 
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occurring in one week was 16, on the week beginning 15th January 2018. Also, with the 
exception of two alarms, all alarms occurred in either winter or spring (Table 2.5). 
 
Scotland offered initiatives throughout the study period, hence including these in the baseline 
period was unavoidable. However, the baseline period was adapted to minimise any initial 
effect from the start of the SSSI. The baseline used was the 4-year period from week 1 of 
2005 to the end of 2008, therefore allowing for analysis using the TADA from the start of 
2009 to the end of 2018. The TADA yielded four alarms, two in 2010, one in 2015 and one 
in 2016 (Figure 2.10). Of the two alarms raised in 2010, the second was raised in week 51, 
beginning the 20th December, the week after the introduction of the sheep scab order (Figure 
2.7).  
 
Figure 2.8: Time-series plot with a temporal aberration detection algorithm 
(TADA) applied for the count of Veterinary Investigation Diagnosis Analysis 
(VIDA) positive scrapes in England from week 1 of 2010 to the end of 2018, 
using a reference period of week 1 of 2006 to the end of 2009. Red triangles 
indicate alarms raised by the TADA, showing a significant deviation from the 
expected count. 
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Figure 2.9: Time-series plot with a temporal aberration detection algorithm 
(TADA) applied for the count of Veterinary Investigation Diagnosis Analysis 
(VIDA) positive scrapes in Wales from week 1 of 2007 to the end of 2018, using 
a reference period of week 27 of 2004 to the end of 2006. Red triangles indicate 
alarms raised by the TADA, showing a significant deviation from the expected 
count. 
Figure 2.10: Time-series plot with a temporal aberration detection algorithm 
(TADA) applied for the count of Veterinary Investigation Diagnosis Analysis 
(VIDA) positive scrapes in Scotland from the beginning of 2009 to the end of 
2018, using a reference period from the beginning of 2005 to the end of 2008. 
Red triangles indicate alarms raised by the TADA, showing a significant 
deviation from the expected count. 
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Table 2.5: Alarms raised by the temporal aberration detection algorithm (TADA) applied 
to England, Wales and Scotland. Periods monitored: England 2010-2018; Wales 2007-
2018; Scotland 2009-2018. Week is the week number in accordance with the ISO 8601 
standard. The upper threshold is the number of counts, as determined by the TADA, which 
would need to be exceeded before an alarm is generated. 





threshold Year Week 
England 2010 39 4 3.45 
Wales 2008 26 4 3.83 
 
2015 51 5 3.75 
 
2016 52 5 3.78 
 
2017 51 8 4.24 
 
2017 52 9 4.24 
 
2018 2 12 4.96 
 
2018 3 16 4.44 
 
2018 5 7 3.63 
 
2018 6 4 3.36 
 
2018 7 5 3.37 
 
2018 8 6 3.37 
 
2018 9 5 3.65 
 
2018 10 4 3.14 
 
2018 11 4 2.34 
  2018 38 3 2.67 
Scotland 2010 10 3 2.96  
2010 51 6 5.35  
2015 53 3 2.64  
2016 51 5 4.07 
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2.4. Discussion 
As with many endemic diseases in GB, sheep scab will not be eradicated without 
considerable effort and long-term commitment from all stakeholders, requiring a high level 
of investment from both the government and the industry. This is further complicated by the 
highly variable prevalence of this disease within the country. Therefore, the development of 
targeted, sustainable and cost-effective strategies is paramount to the future success of 
disease control. In this chapter, one of the aims was to investigate an existing data source for 
the scanning surveillance of sheep scab in GB (the VIDA database), to identify current trends 
and geographical "hotspots" for sheep scab. In contrast to previous studies which indicated 
an increasing or stable prevalence (Bisdorff et al., 2006; Chivers et al., 2018; Rose et al., 
2009), data in this study showed a decline in the annual counts of positive scrapes in all 
countries of GB, with the exception of 2018. The monthly distribution of positive scrapes 
was similar to the expected seasonality for sheep scab (French et al., 1999), and the spatial 
distribution of positive scrapes also displayed a pattern comparable to previous studies, with 
high counts observed in Wales, northern Scotland and northern England. This would suggest 
prioritizing these areas for future targeted control strategies. While these raw counts cannot 
be used to infer disease prevalence, the application of a denominator, as the ones proposed 
here, could aid interpretation of these counts.  
The deregulation of the mandatory organophosphate sheep dipping saw the prevalence of 
sheep scab in GB increase to an endemic level (Nieuwhof and Bishop, 2005). More recently 
however, results from a postal study in Wales suggested the prevalence had remained stable 
over the past 10 years (Chivers et al., 2018). Here, the count of positive scrapes significantly 
decreased across the 16 years, a similar trend observed in all three potential denominators 
(Figure 2.4). This strongly supports the hypothesis that the prevalence of sheep scab has 
remained relatively stable over the study period, while the submission of diagnostic samples 
has reduced, impacting on the overall count of positive scrapes. This could be explained by 
fewer confirmatory diagnoses being sought by vets and farmers. As holdings which 
previously had sheep scab outbreaks have been shown to be significantly more likely to have 
further outbreaks (Rose et al., 2009), once the disease has been diagnosed farmers may opt 
to treat any subsequent outbreaks without investigating further. The reduction in the 
submission for diagnostic sampling may also be influenced by the cost, which currently 
stands at £24.70 per ectoparasite screen excluding any veterinary call out fees in England 
and Wales (APHA, 2020b). This is a particular concern for hill and upland flocks where only 
the top producers make any net profit (Harvey and Scott, 2020; Quality Meat Scotland 
  51 
 
[QMS], 2017). In Scotland, the submission of ectoparasite screens for suspected sheep scab 
cases has been free since 2002 (SRUC, 2018), so the decision to submit samples for testing 
is unlikely to have such financial bearing. In addition, the closure of some VICs across 
England and Wales in 2013 and 2014 (Veterinary Record, 2011) may have influenced the 
willingness of veterinarians to submit samples to the APHA for diagnosis. Sheep scab is 
diagnosed by the APHA and SRUC through the submission of samples which can be posted, 
and while this effect should have been minimal, the loss of the relationships formed between 
centres and veterinarians (House of Commons Environment Food and Rural Affairs 
Committee, 2011) may have caused a more significant decline. Finally, over time, veterinary 
practices may have opted for an increase of in-house or on-location testing of samples. These 
results are currently lost from a surveillance point of view. 
Somewhat unexpected after the sustained annual decline, was the substantial increase in 
positive scrapes in 2018, to 2.5 times the counts of the previous year. In Wales, the APHA 
free testing initiative which occurred from December 2017 to March 2018 (Table 2.4) saw a 
500% increase in submissions (APHA, 2018b), and likely contributed significantly to this 
increase. However, no known initiatives were employed during this time in England and 
Scotland. Therefore, the increase may have been a residual effect from increased awareness 
of sheep scab as a result of promoting the welsh scheme (APHA, 2018a), or due to regional 
disease awareness campaigns after the first reported cases of resistance (Doherty et al., 
2018), which were not captured in this study (French et al., 1999). 
The "hotspots" (areas with high numbers of confirmed cases) identified in the VIDA data 
were similar to previous studies, with high counts occurring in Wales and northern Scotland 
(French et al., 1999; Rose et al., 2009). This could support the use of the VIDA database as 
a suitable means of scanning surveillance, creating a continuous evidence-base for the 
targeting of disease control initiatives. With further refinement of the geolocators (for 
example to a parish level), the spatial distribution of positive scrapes could aid the 
development of localised control programmes.  
One of the commonly reported challenges for the use of the VIDA database to inform 
prevalence is the submission bias. As a diagnostic database, submissions of suspected cases 
are made voluntarily, and thus might not be representative of the total population at risk. 
This introduces an important source of selection bias, as submission might be influenced by 
different factors, like geographical location, awareness and attitudes towards the disease, 
economic values (of both the disease and animals), the density of animals in an area, and the 
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number of animals affected (APHA, 2019a). Consequently, the number of positive scrapes 
might not represent the true prevalence of the disease; however, these data are considered of 
high quality due to the rigorous quality of the test from the UKAS accreditation. To account 
for the spatial distribution of sheep scab in relation to the sheep population, a denominator 
such as total sheep population from the yearly June agricultural census (National Statistics, 
2019) or density of sheep per holding could be applied to the positive scrapes. These 
denominators could help highlight additional "hotspot" areas where the sheep population 
might be small, but many animals are infested (CDC, 2020). It would also help to 
differentiate between areas of low disease burden despite having a high density of sheep 
population versus areas with a low density of sheep population. In this study, for example, 
eight regions (six in England and two in Scotland), had zero positive scrape diagnoses 
between 2003 and 2018. Some of these areas may be highly industrialised with low density 
sheep populations which could explain the lack of sheep scab diagnoses, but in others, it 
could represent a low presence of disease. As mentioned before, geographical locations can 
also have a significant impact on submission of diagnostic samples. In the case of Eileanan 
an Iar (the Western Isles off the north west coast of Scotland), since the introduction of the 
Sheep Scab (Scotland) Order in 2010, the Scottish Government reported 32 sheep scab 
notifications in this region between 2010 and 2019 (APHA, 2020b), yet no positive scrapes 
were recorded in the VIDA database. Therefore, this suggests that diagnoses have either not 
been pursued or are confirmed in a different way (e.g. through private veterinarians). It is, 
however, important to highlight here that these are very different datasets; with the Scottish 
Government notification data holding a record of suspected cases, and the VIDA database 
only confirmed positive diagnoses. Yet, there is no particular incentive for farmers to raise 
a notification for sheep scab if the disease is not present. However, from both databases it is 
clear that sheep scab is likely vastly underreported in GB, which may be at least in part due 
to the historic but still present stigma towards the disease among the farming community. 
Since denominators such as total sheep population were not easily accessible for use in this 
study and would not be continuously available for the interpretation of the positive scrapes, 
alternative denominators were sought from the VIDA database itself to enhance the 
interpretation of the positive scrapes. The total diagnostic submissions dataset offered an 
insight into the number of diagnostic submissions made across the SRUC VS and the APHA, 
but positive scrapes represented only a very small proportion of the total submissions due to 
the number of other diagnoses made which are included in the VIDA database. However, it 
is important to have an awareness of the overall trends in diagnoses being made when 
interpreting the positive scrape data, to understand external factors which may have 
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influenced the overall submission rate, such as the VIC closures in 2013 and 2014. In 
contrast to the number of submissions in the total diagnostic submissions, the count of 
submissions in the scrape submissions dataset was predominantly lower than the number of 
positive scrapes. This demonstrates that this dataset does not incorporate all sources from 
which sheep scab diagnoses are being made, and as such does not offer a suitable 
denominator to contextualise the number of positive scrape submissions. The skin 
submissions and scheduled scrapes datasets both related well to the annual pattern of sheep 
scab diagnoses, and therefore either could potentially be applied as a denominator to 
contextualise the number of positive scrapes. The main difference between these 
denominators was that the skin submissions dataset represents all submissions where the 
presenting complaint was listed as skin problem by the submitting private veterinarians, and 
the scheduled scrapes dataset was the number of tests scheduled by the VIO to diagnose 
suspected sheep scab. The skin submissions dataset, as a denominator, could, therefore, 
determine (i) the proportion of positive sheep scab submissions in the context of overall 
submissions with suspected skin diseases and (ii) whether other ectoparasites were involved 
when sheep scab was suspected. From this study, almost 30% of the skin submissions were 
positive for sheep scab, which confirms sheep scab as a significant problem in the context 
of skin diseases in sheep. By analysing the dataset for other VIDA codes, further insight into 
other ectoparasites (i.e. lice) as a differential diagnosis for sheep scab could be available. 
Meanwhile, scheduled scrapes included all diagnostic tests conducted to diagnose suspected 
sheep scab, so is likely more appropriate when considering the proportion of suspected cases 
which were eventually diagnosed as positive, and perhaps more importantly, negative. In 
this study, 46% of the scheduled scrapes were positive and, as such, over half of the tests 
conducted were negative. This highlights that even when sheep scab was suspected, it was 
more than half of the time not diagnosed. The application of these datasets as potential 
denominators share similar caveats as they cannot be used to infer prevalence (they are not 
representative of the population at risk). However, the use of these denominators is valuable 
to contextualise the counts of positive scrapes. Furthermore, both of these denominators 
were easily extracted from the database and share the same format as the positive scrapes. 
This made their analysis significantly easier than other datasets, and thus would promote 
their continued use as suitable denominators. 
The second aim of this chapter was to investigate the impact of past disease control initiatives 
and therefore give recommendations for their future use. The information about the sheep 
scab control initiatives described here were only available through the organisation(s) that 
coordinated them, or from personal correspondence. With the exception of results from the 
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APHA free testing in December 2017 to March 2018 being published in a quarterly disease 
surveillance report (APHA, 2018b) and a survey measuring the impact of the SSSI (ADAS, 
2008), information on the outcome on the majority of initiatives was unavailable and thus 
made it impossible to determine whether these initiatives were successful without first-hand 
experience. It was also often difficult to locate information which pertained to the 
operational dates or original objectives of the initiatives as sources were not available 
publicly. This study has highlighted that there is considerable value in retaining details about 
these events in the public domain, not only to avoid specific knowledge being only available 
to the coordinating organisations (and often only to a few people) but also to avoid this 
knowledge being lost or forgotten. Therefore, to facilitate a more effective approach to 
information storage about sheep scab control initiatives, it may be beneficial to consider 
instating a UK-wide database, similar to the USA's centers for disease control and 
preventions (CDCs) list of national health initiatives which covers a range of diseases 
important to human health (CDC, 2020). In addition to compiling information on past 
initiatives, if used prospectively for activities still in the planning phase, a database could 
encourage support from other stakeholders. This could ultimately offer a more cost-effective 
alternative by increasing the impact of each individual disease control programme. 
Currently, the adoption of a database could be particularly valuable between England and 
Wales, where control strategies have in the past been very similar. 
The impact of the initiatives was measured using a TADA, a technique commonly used to 
detect outbreaks of pathogens in healthcare settings (Yuan et al., 2019). Limited previous 
work has been conducted to investigate the impact of different types of disease control 
initiatives (ADAS, 2008); however, the application of the TADA could offer a near real-
time evaluation. A number of TADAs, including the original Farrington (Farrington et al., 
1996), improved Farrington (Noufaily et al., 2012), CUSUM, and negative binomial 
(Salmon et al., 2016), were considered for this study. Ultimately, the original Farrington 
method was selected as it worked well for highly seasonal data and allowed a shorter baseline 
period for the model training before convergence was achieved. This was required to 
minimise the potential aberration within the baseline periods and maximise the number of 
initiatives which could be studied. However, the original Farrington methodology does not 
account for sustained shifts in the counts, which could have increased the sensitivity of the 
model. The performance of each TADA is also highly reliant on the quality of the baseline 
period supplied. This was very much variable for each country due to conflicts with 
initiatives, and high counts at the beginning of the study period which prevented model 
convergence, notably for England's TADA (Figure 2.8). In addition, it is possible that 
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aberrations occurred during the baseline which were not known, thus could not be accounted 
for.  
The most common initiatives for targeted sheep scab disease control were 'free testing' 
initiatives, which accounted for 8 out of 11 initiatives. The majority of resulting aberrations 
aligned with one period of APHA free testing from December 2017 to March 2018 in Wales, 
which indicates that free testing provoked an increase in diagnostic submissions, achieving 
one of the main goals of these kind of initiatives. Compared to all of the other sheep scab 
initiatives in this context, free testing is much easier to implement and coordinate and, above 
all, offers a cost-effective way to increase testing at a specific point in time. This suggests 
that free testing is a suitable way to capture the initial interest from farmers, but more often, 
only long-term education through knowledge transfer or knowledge exchange can produce 
lasting changes in mindset and behaviour (O’Kane et al., 2017) that could ultimately 
decrease the incidence of sheep scab. However, as shown, the impact of knowledge transfer 
activities is more difficult to quantify. No aberrations specifically aligned with initiatives 
such as 'Stamp out Scab' where the initiative type was 'knowledge transfer & skills training'. 
This was likely as the aim of this initiative was not to directly impact the number of 
submissions but to increase the overall awareness of the disease instead. As such, even 
though knowledge transfer activities require much more coordination, incur significant cost, 
and require significantly more commitment from all involved, they should not be 
discontinued. In future, to effectively measure their impact, alternative methods such as the 
survey conducted after the SSSI (ADAS, 2008) which measured overall awareness of the 
initiative, could be adopted to complement the use of the TADA. 
Concerning the TADA, Scotland was in a unique position with initiatives in place throughout 
the study period. Therefore, the baseline period had to be set within the SSSI, which likely 
meant a higher baseline than expected. Despite this, alarms were still generated: one at the 
introduction of the new legislation, and a further two within the notifiable period, suggesting 
the alarms generated may be representative of true aberrations. The pressure to achieve sheep 
scab control in Scotland has been predominantly led by industry, which shows that there was 
a desire in the country to achieve control of sheep scab. Ultimately, this pressure led to the 
creation of the notification status. Even so, the notifiable status on its own is unlikely to 
result in eradication. Continuous and active strategies such as knowledge transfer will need 
to be adopted on top of this to maintain the desire to reach eradication and increase the 
knowledge about as the initiatives caused an increase in positive scrapes sheep scab. 
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To summarise, the impact of free testing and legislation initiatives could be measured with 
the TADA analysis as the initiatives caused an increase in positive scrapes. The further use 
of this method is therefore promising for the application to other endemic diseases and takes 
into consideration a number of factors including prevalence, awareness, economic burden, 
and current disease control methods.  
In conclusion, the further analysis of the existing scanning surveillance source, the VIDA 
database, enhanced our knowledge of sheep scab by identifying potential "hotspot" areas for 
targeted disease control initiatives. It shows a decline in overall submissions, strong seasonal 
pattern and confirmed that Wales in particular is an area to focus on for future control efforts. 
Furthermore, two alternative denominators (skin submissions and scheduled scrapes) 
extracted from the VIDA database itself, have potential value for the further interpretation 
of positive scrapes. Finally, the TADA offered a framework to objectively measure the 
impact of targeted disease control initiatives, something that is being advocated widely as a 
more cost-effective and sustainable approach to the long-term control of endemic diseases 
and as a complementary tool in scanning surveillance. 
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3. Evaluating the use of commercial diagnostic 
data to enhance the scanning surveillance of sheep 
scab 
3.1. Introduction 
The integration of new data sources is being increasingly recognised as a potentially cost-
effective strategy to add value to the existing scanning surveillance for many diseases, 
particularly endemic diseases (Middlemiss et al., 2018). The scanning surveillance of sheep 
scab is currently achieved through the VIDA database, as discussed in Chapter 2; however, 
the recent commercialisation of the sheep scab ELISA may present new opportunities to 
inform control strategies. 
As previously described in 1.2.3.1, the sheep scab ELISA offers a new approach to the 
diagnosis of sheep scab versus the conventional skin scraping methodology, using blood 
samples to provide a highly sensitive and specific diagnosis of sheep scab at a clinical and 
subclinical level (Burgess et al., 2012). The sheep scab ELISA can be applied to diagnose 
individual sheep, but also provides a powerful estimation of serostatus at a flock level using 
a 12-sample screening, even with low mite burden (Hamer et al., 2019). This has particular 
value for monitoring flocks as part of a proactive disease management strategy. The sheep 
scab ELISA detects a rise in antibody levels to the Pso o 2 allergen as early as 2 weeks post 
infestation, and thus is able to detect subclinical cases several weeks before clinical signs 
develop (Burgess et al., 2012). Furthermore, the retesting of flocks 10 days post-treatment 
can show decreasing antibody titres to prove efficacious treatment, which could be 
particularly valuable with the emergent resistance (Hamer et al., 2019).  
To prevent outbreaks and guide the management of sheep scab, as with most diseases, it is 
also important to consider factors which may impact the risk of transmission. For sheep scab 
it has previously been shown that the use of common grazing (where multiple holdings graze 
their sheep on the same land without boundaries) resulted in a significantly higher prevalence 
of sheep scab and an increased chance of repeated outbreaks (Cross et al., 2010; Rose and 
Wall, 2012). In addition, land at a higher altitude has been shown to have a higher prevalence 
of sheep scab than lower altitude (Vineer, 2011). Current guidance to reduce the transmission 
of sheep scab includes recommending good general biosecurity, such as minimising contact 
with neighbouring animals through the use of double fencing, minimising shared facilities, 
and the use of contractors for dipping and shearing (ADAS, 2008). However, there is 
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currently little scientific evidence surrounding the impact of many of these, often costly, 
biosecurity measures for sheep scab.  
Using data from the recently commercialised sheep scab ELISA diagnostic test, this chapter 
aims to enhance our knowledge and understanding for the scanning surveillance of sheep 
scab. Through digitisation of all data from the sheep scab ELISA, it aims to provide a new 
usable source of data. It then aims to use this data to provide information on the current use 
and uptake of the sheep scab ELISA and investigate the risk associated with certain 
management practices. Finally, this chapter also aims to consider the potential value of the 




3.2. Materials and methods 
3.2.1. Data collection and collation 
3.2.1.1. Data description 
Biobest Laboratories Ltd ("Biobest") is a commercial laboratory based near Edinburgh, 
Scotland, that specialises in diagnostic testing for infectious diseases in both livestock and 
companion animals. In February 2017 they commenced operation of a sheep scab antibody 
ELISA test (herein referred to as 'sheep scab ELISA'), which was developed at Moredun 
Research Institute (MRI). As of September 2020, Biobest were the only company operating 
the sheep scab ELISA in the UK.  
All samples submitted to Biobest from one holding are defined as a submission, therefore a 
single submission can contain any number of blood samples. As the test is designed primarily 
to detect subclinical cases and for monitoring purposes, 12 blood samples should be drawn 
from individuals within each flock or management group (separate groups of sheep on the 
same holding). This is based on previous statistical analysis, providing a powerful estimation 
of the serostatus at the flock level for flocks/management groups of up to 2,000 animals 
(Hamer et al., 2019) i.e. whether the whole flock/group should be considered infested 
(positive) with sheep scab or not (negative). Each submission and its corresponding 
laboratory results are linked by a 6-digit unique identifying code, and each sample within 
the submission is distinguished by a 7-digit unique identifying code. 
Two datasets were available for this research: the 'submission forms' and 'result report'. The 
submission forms, an example of which is displayed in Appendix 4, consist of two A4 sides 
of questions. These are received by the laboratory as a hand-filled paper copy accompanying 
each submission, with the purpose to offer information for interpretation of the results report. 
For long-term storage of the submission forms, they are scanned and added to a rolling PDF 
document which captures all submission forms submitted to the laboratory. The results 
report is a PDF document extracted from Biobest's Laboratory Information Management 
System (LIMS). The report captures all of the individual sample results (distinguished by 
their 7-digit unique identifying code) for the sheep scab ELISA grouped by the submission's 
6-digit unique identifying code, as shown in Appendix 5. All samples are tested in duplicate; 
therefore, the result for each sample is an average of the optical density (OD) observed in 
each well. When the variance between OD results exceeded 20%, samples were retested. 




3.2.1.2. Database creation 
Before September 2019 (the start of this project), no database existed that collated the 
submission forms and result report. Therefore, the data were manually digitised from the 
PDF files. Data were captured from both datasets from the 1st February 2017 to the 31st 
August 2019, a period of 31 months. 
As a first step, data from the results report were recorded in a Microsoft Excel spreadsheet. 
This totalled 4 fields: the date of reporting, the 6-digit unique identifying code for the 
submission, the 7-digit unique identifying code for the sample, and the associated OD 
result(s) for each sample. Each result report also included a written interpretation of the OD 
results, written by the veterinary staff at Biobest (data not captured), which assessed the 
flock’s or management group’s serostatus based on the OD values and answers to the 
submission form fields. Then, the data from the submission form, totalling 35 fields (as 
detailed in Appendix 6), were digitised from the original PDF and recorded in a further 
Microsoft Excel spreadsheet. 
3.2.1.3. Data cleaning 
After collation, the data were cleaned to unify terminology, fix misspellings, and correct the 
formatting of certain variables (i.e. dates) in order to prepare them for analysis. Due to lack 
of information as submission forms were not completed, 209 of the 542 submissions forms 
were excluded from the analysis. 
For 20 of the 3,089 samples analysed more than one OD result was recorded. To avoid 
duplication, only one result was analysed for each sample. In these cases, the sample result 
selected was determined by making use of the written interpretation from the original result 
report (described in 3.2.1.2).  
To locate the geographical provenance of the samples, two fields, 'holding number' and 
'postcode' were captured from the submission form (Appendix 6). The holding number, also 
known as the county-parish-holding number (CPH), is a unique 9-digit number given to each 
holding that is registered to keep livestock. The first two digits pertain to the county, the next 
three to the agricultural parish, and the final four digits to the unique holding within the 
agricultural parish (e.g. 01/001/0001). For the purposes of our analysis and to maintain 
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anonymity, the holding numbers were retained to the agricultural parish level only (first 5 
digits). The holding numbers were then used to obtain spatial coordinates (longitude and 
latitude) from the APHA's parish shapefile (as in Chapter 2). Similarly, postcodes are a 5 to 
7-digit alphanumeric code split in two halves, one of 2-4 digits, the other with 3 digits, which 
defines a specific location for mail deliveries in the UK, often with several properties sharing 
one postcode. The first 1 or 2 digits of the postcode defines a particular region, e.g. IV = 
Inverness. The remaining digits (numerals) within the first half pertain to a specific part of 
the region, and the last half further refines the location to the street. To obtain the spatial 
coordinates of the submission from the postcode, the publicly available ONS's National 
Statistics Postcode Lookup from February 2019 (Office for National Statistics, 2019a) was 
used. If both the postcode and holding number were available for a submission, the postcode 
was chosen in preference due to increased location accuracy. 
Of the 35 fields digitised from the submission forms, four ('contract shearing', 'contract 
dipping', 'shared gathering facilities' and 'shared livestock trailers') required the farmer or 
veterinarian to circle any of the options that applied to the holding. As no escape option to 
opt out from these categories (e.g. 'other – please specify') was provided, all types of marking 
(e.g. circle, striking a line etc.) were considered a positive response. If no mark was applied 
to the specific question, but the submission form was otherwise well completed, this was 
interpreted as a negative response.  
 
3.2.2. Data analysis 
All databases were created in Microsoft Excel 365. All analyses and visualisations, unless 
otherwise stated, were performed in R version 4.0.0 and RStudio.  
 
3.2.2.1. Calculated serostatus 
Individual sample results are categorised at Biobest into three possible outcomes dependent 
on their OD: negative, suspect, or positive (see Table 3.1). Where single samples are 
submitted, this is considered the final result (serostatus). Where multiple samples are 
included in a submission, interpretation of the single results to provide the overall 
submission serostatus is achieved using the information from the submission form and, 
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ultimately, the judgement of the experienced Biobest veterinarian. However, this research 
project is part of a wider collaborative network (DEFRA – Lot 2 Antiparasitic Resistance: 
Sheep Scab) among which a standardised dichotomous interpretation of submission 
serostatus has been developed (Innocent, G., unpublished). Therefore, this newly developed 
framework has been applied here to provide an interpretation of the sample results within 
each submission, irrespective of the number of samples included within the submission.  
Table 3.1: Cut-off values used to determine the serostatus of individual samples. The result 
is the average OD value from duplicates of the sample, multiplied by a factor of 100. 
OD Result Interpretation 
£ 39 Negative 
40-49 Suspect 
³ 50 Positive 
 
The new framework uses a Bayesian approach allowing the inclusion of prior knowledge 
about the animal's probability of having a positive result, combined with the test result to 





The prior, denoted as P(positive), is the probability that the animal is positive without a test 
and is calculated using existing knowledge about the animal's individual risk of disease. The 
prior value is multiplied by P(test result | positive), which is the probability of the test result 
if that animal is positive, directly calculated from a distribution of positive test results from 
animals with known serostatus. P(test result) is the probability of the test result, calculated 
as P(test result | positive)P(positive) + P(test result | negative)P(negative), where P(test 
result | negative) is directly calculated from a distribution of negative test results from 
animals with known serostatus, and P(negative) as the prior probability that the animal is 
negative without a test (Innocent, G., unpublished). 
The above method was used to interpret the probability of an individual sample testing 
positive using a prior value of 0.1, assuming a 10% prevalence of sheep scab in the UK 
(Bisdorff et al., 2006). Then, this was converted to a submission level serostatus (where 
multiple samples were included in a submission) by calculating the mean of posterior values 
for all samples within each submission. A cut-off threshold was then applied to determine 
whether the submission was positive or negative, calculated as 1/2n, where n is the number 
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of samples in the submission. If the mean of the posterior values for the submission was 
higher than the chosen threshold, the flock serostatus was interpreted as positive, and if it 
was lower it was interpreted as negative. 
3.2.2.2. Descriptive analysis 
The date captured from the result report was used to visualise the temporal pattern of the 
sheep scab ELISA submissions per month since its commercialisation. Then, to assess 
whether the sheep scab ELISA was used primarily as a tool for flock screening (submissions 
of 12 samples) or for individual diagnosis, the number of blood samples within each 
submission was aggregated into groups (from '1' to '12' samples in a submission). Any 
submissions containing more than 12 samples were grouped together into a further category, 
'>12'. 
Using spatial coordinates from the submission forms (as previously described in 3.2.1.3), a 
descriptive spatial analysis was performed to visualise the spatial distribution of submissions 
since the commercialisation of the sheep scab ELISA. Points were plotted on a UK shapefile 
obtained from the Office of National Statistics, at Nomenclature of Territorial Units for 
Statistics (NUTS) level 2 (Office for National Statistics, 2019b). Each individual point was 
coloured based on the calculated serostatus as described in 3.2.2.1, red for positive and blue 
for negative. For two remote holdings, the points were moved to the nearest populated area 
to avoid identification. 
To evaluate the completeness of the submission forms, all fields were counted, divided by 
the total number of submission forms and multiplied by 100 to produce a percentage. To 
establish whether there was a significant difference between the completion of the two pages, 
the completion rates of page 1 were compared with page 2 by performing a two sample t-
test. 
To further explore the use of the sheep scab ELISA, the 'farm type' and 'reason for testing' 
were analysed. The 'farm type' refers to the primary land type of the holding. Three farm 
type categories: 'lowland', 'upland' and 'hill', were presented as options to circle. If multiple 
options were circled, they were categorised into an additional 'mixed' category. Meanwhile, 
the 'reason for testing' is why the holding submitted for sheep scab ELISA testing. On the 
submission form the reason for testing field included four options: itchy, monitoring, 
quarantine, or other. However, within the 'other' category (a free text area), two further 
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reasons for testing ('wool loss' and 'retest') presented multiple times, so were used as 
additional categories, as shown in Table 3.2. Then, to establish whether the farm type had 
an effect on the reasons for testing, the reasons for testing were visualised as a proportion of 
the total submissions for each of the four farm type categories. 
 
Table 3.2: Options for “Reason for testing” available in the submission form and their 
description 
Reason for Testing Description 
Itchy Samples are submitted for the diagnosis of itchy 
animals (i.e. animals with clinical signs of sheep 
scab). 
Monitoring Samples are submitted for monitoring of clinically 
healthy animals (i.e. no clinical signs of sheep 
scab). 
Quarantine Samples are submitted for testing of bought-in or 
returning animals (i.e. animals in quarantine). 
Retest Samples are submitted for retesting of flocks 
which had a previous positive diagnosis. 
Wool loss Samples are submitted for animals displaying 
signs of wool loss, but not itchy. 
Other Samples are submitted for reasons which did not 
fit into the previous categories. A free text option 
was available to specify the reason. 
 
3.2.2.3. Risk factor analysis 
To establish whether specific factors had a significant relationship to the calculated 
serostatus, six fields from the submission form database were chosen for analysis: double 
fencing, common grazing, contract shearing, contract dipping, shared gathering facilities, 
and shared livestock trailers. These factors were selected as the data had a completion rate 
which exceeded 50%, and they have previously been identified to, or are commonly thought 
to, influence the risk of sheep scab outbreaks (ADAS, 2008). All fields selected had a binary 
outcome (i.e. 'yes' the variable applied to the holding, or 'no' the variable did not apply to the 
holding). Therefore, a multivariable logistic regression was applied to the six fields to test 
for association to the calculated serostatus. 
In addition, as having a past sheep scab outbreak on a holding has been shown to 
significantly increase the chance of further outbreaks (Rose and Wall, 2012a), separate 
univariate logistic regressions were performed using the fields 'sheep scab previously 
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diagnosed' and 'sheep scab previously suspected' (both within the past two years) to test the 
association with the calculated serostatus. As before, these fields had a binary outcome (i.e. 
'yes' or 'no'). 
3.2.2.4.  Comparison to existing scanning surveillance 
To evaluate the potential use of the sheep scab ELISA data for scanning surveillance, the 
sheep scab ELISA submissions with a positive serostatus were compared to the count of 
VIDA positive scrapes. The VIDA positive scrapes (as previously described in 2.2.1) were 
a subset from the whole database matching the study period of the sheep scab ELISA, with 
both datasets aggregated by month to facilitate a descriptive temporal analysis. To compare 
the spatial distribution of these two datasets, the VIDA positive scrapes visualised by the 
regional geolocator previously described in 2.2.2.1 were overlaid by the sheep scab ELISA 





3.3.1. Calculated serostatus 
A total of 542 submissions were received and tested between the 1st February 2017 and 31st 
August 2019. Of the 542 submissions, 333 (comprising of 2,375 blood samples) had 
sufficient submission data for inclusion in the analysis. As two submissions, comprising of 
24 samples, were performed at the MRI using different reagents, these were excluded from 
all analyses using serostatus, leaving 331 submissions, comprising of 2,351 blood samples. 
Using the OD cut-off values as described in Table 3.1, 82.7% (n = 1,945) of the 2,351 blood 
samples had an OD result classified as negative, 13.8% (n = 324) as positive, and 3.5% (n = 
82) as suspect. Then, using the new framework to present a serostatus for each of the 331 
submissions (each containing between 1 and 53 individual samples) 43.2% (n = 143) 
submissions were classified as positive, and 56.8% (n = 188) as negative. 
   
3.3.2. Descriptive analysis 
As shown in Figure 3.1, a substantial increase in monthly submissions occurred across the 
study period. There were no submissions (n = 0) for the months of April, May and July 2017. 
The maximum number of submissions occurred in the last month of the study period, August 
2019 (n = 38). Some seasonal variation was observed, with higher numbers of submissions 
being made in autumn and winter. This was particularly evident across early 2019 when the 





Figure 3.1: Monthly trend of sheep scab ELISA submissions (n = 333), from February 
2017 - August 2019 inclusive. 
 
The largest percentage of submissions (30.6%, n = 102) contained the recommended 12-
samples, as displayed in Figure 3.2. Single sample submissions were the next most frequent, 
representing 24.0% (n = 80) of the total submissions. Submissions which included between 
1 and 11 samples represented 63.1% (n = 210) of the total, while 6.3% (n = 21) contained 






In total, 289 of the 331 sheep scab ELISA submissions included a geolocator which allowed 
spatial coordinates to be obtained for plotting. Of these submissions, 67.7% (n = 195) 
originated from England, 27.1% (n = 79) from Wales, 4.8% (n = 14) from Scotland and 0.3% 
(n = 1) submission from Northern Ireland (Figure 3.3). Submissions derived from 30 of the 
total 41 NUTS level 2 regions in the UK. There were no submissions (n = 0) made in 11 
regions, 10 of which were in England and one in Scotland. There was no significant 
difference between the number of positive and negative serostatus in regions where 
submissions were made (p > 0.05 using a chi-squared test).  
In England, submissions predominately derived from the west and south of the country 
(Figure 3.3). The highest number of submissions in England were from: Cumbria (n = 40); 
Shropshire and Staffordshire (n = 25); Derbyshire and Nottinghamshire (n = 19); 
Northumberland and Tyne and Wear (n = 19) and East Anglia (n = 14). In Wales, the 
Figure 3.2: Number of samples contained within a submission, as a 
percentage of total submissions (n = 333). 
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majority (n = 50) of the submissions originated from one region, West Wales and The 
Valleys. This was the highest number in a single region across all countries. Scotland had a 
much lower number of submissions, with the highest number from Eastern Scotland (n = 7), 
followed by the Highlands and Islands (n = 5).  
 
The percentage of data completeness for all fields captured from the submission form is 
shown in Figure 3.4. Of the 35 fields, 48.6% (n = 17) had over 50% completion. The median 
percentage of completion across the fields was 44.1%. The variables from page 1 of the 
submission form (Appendix 4A) had an average completion of 53.2%, which was 
Figure 3.3: Spatial distribution of the sheep scab ELISA submissions from 
February 2017 to August 2019 inclusive (n = 289). Colour of the point 
indicates the calculated submission serostatus: red = positive, blue = negative. 
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significantly different to the completion of the variables on page 2 (Appendix 4B), of 20.1% 
(p < 0.001). 
 
Figure 3.4: Percentage completeness for all fields captured from the sheep scab 
ELISA submission forms (n = 333). 
Field               Completeness  
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Of the 261 (78.4%) submissions which indicated the reason for testing, 'itchy' was the most 
frequent reason for submission, representing 56.7% (n = 148) of the total submissions. The 
second most frequent reason was for 'monitoring', 32.6% (n = 85) of submissions. The other 
reasons for testing cumulatively represented 10.7% (n = 28) of submissions as shown in 
Table 3.3. In addition, of the 56 submissions which only contained one sample, 87.5% (n = 
49) were submitted due to 'itchy' sheep, with the remaining 12.5% (n = 7) submitted for 
either quarantine, retests, wool loss or 'other' reasons. No submissions (n = 0) containing 
only one sample were submitted for monitoring. In contrast, of the 82 submissions 
containing 12 samples, 65.9% (n = 54) were submitted for monitoring, 29.3% (n = 24) were 
submitted for the diagnosis of 'itchy' sheep, and the remaining 4.8% (n = 4) for quarantine, 
retests and 'other' reasons. 
Table 3.3: Reasons submissions were made for the sheep scab ELISA test (n = 261). 
Reason Number of submissions Percentage (%) 
Itchy 148 56.7% 
Monitoring 85 32.6% 
Quarantine 11 4.2% 
Retest 11 4.2% 
Wool loss 2 0.8% 
Other 4 1.5% 
 
The 'farm type' was indicated for 229 submissions. Almost half of submissions originated 
from 'lowland' flocks (48.9%, n = 112). The count of submissions received from both 'upland' 
and 'hill' flocks were similar (Table 3.4), with only a small percentage (4.8%, n = 11), 
originating from 'mixed' flocks.  
Table 3.4: Primary farm type of submitting holdings (n = 229). 
Farm Type Number of submissions Percentage (%) 
Hill 54 23.6% 
Upland 52 22.7% 
Lowland 112 48.9% 
Mixed 11 4.8% 
 
The relationship between 'reason for testing' and 'farm type' is shown in Figure 3.5. 
Submissions from lowland flocks were mostly from itchy sheep, representing 75.5% (n = 
80) of the total lowland submissions. This proportion decreased to 52.1% (n = 25) for upland 
flocks and 34.0% (n = 17) for hill flocks. For mixed farm types, submissions from itchy 
sheep represented only 27.3% (n = 3) of total submissions. Conversely, lowland farms had 
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the lowest proportion of submissions for monitoring, at 14.2% (n = 15), while upland and 
hill farms represented 43.8% (n = 21) and 60.0% (n = 30) respectively. Mixed land types 
had the highest percentage of submissions submitted for monitoring, 72.7% (n = 8).  
 
 
3.3.3. Risk factor analysis 
Six fields as previously described in 3.2.2.3 were assessed as potential risk factors of sheep 
scab. During model selection, three of the fields ('contract shearers', 'shared gathering 
facilities' and 'shared livestock trailers') were removed from the analysis as there was no 
evidence that these factors, which were orthogonal to the remaining ones, had a clear 
influence on the dependent variable of interest, with p-values exceeding 0.6. A significant 
negative relationship was observed between 'double fencing' and positive serostatus (Table 
3.5). A marginally significant positive correlation was shown between 'contract dipping' and 
positive serostatus, while 'common grazing' did not have any association to the calculated 
serostatus. 
Figure 3.5: Distribution of the reasons for testing, grouped by the 
flock's farm type. Each bar represents the proportion of reasons for 
testing, for the submitting farm type: lowland (n = 106), upland (n = 
48), hill (n = 50) and mixed (n = 11). 
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Table 3.5: Output of the logistic regression model. AIC = 225.21. '.' indicates a marginally 
significant p-value between 0.05 and 0.1. '*' indicates a significant p-value between 0.01 
and 0.05. n = 170 sheep scab ELISA submissions used in estimation. 
Coefficient Estimate Std. Error z-value  p-value 
Intercept -0.2654 0.1254 -2.116 0.0344 * 
Common grazing 0.2590 0.2633 0.984 0.3253 
Double fencing -0.5291 0.2519 -2.100 0.0357 * 
Contract dipping 0.5773 0.3009 1.918 0.0551 . 
 
There was no significant association between 'sheep scab previously diagnosed' and positive 
serostatus (p > 0.05). However, a significant positive association was observed between 
'sheep scab previously suspected' and positive serostatus (p < 0.01).  
 
3.3.4. Comparison to existing scanning surveillance 
From February 2017 to August 2019, 268 VIDA positive scrapes and 143 sheep scab ELISA 
positive serostatus were diagnosed. The monthly count of positive serostatus compared to 
VIDA positive scrapes is shown in Figure 3.6. With the exception of a large peak in VIDA 
positive scrapes from December 2017 to April 2019, reaching a maximum of 44 positive 
scrapes in February 2018, the pattern and count of the VIDA positive scrapes was very 
similar to the number of sheep scab ELISA positive serostatus. 
Of the total submissions, 260 (97.0%) VIDA positive scrapes and 128 (89.5%) sheep scab 
ELISA positive serostatus included a geolocator. The sheep scab ELISA positive serostatus 
were then overlaid on the VIDA positive scrapes as shown in Figure 3.7. The highest number 
of VIDA positive scrapes across the study period originated from Wales, which represented 
63.8% (n = 166) of the total positive scrapes. Scotland then represented 20.8% (n = 54) 
positive scrapes, while England had the lowest proportion observed, at 15.4% (n = 40) of the 
total positive scrapes. In contrast, 70.3% (n = 90) of the sheep scab ELISA positive serostatus 
were from England. Of the remaining positive serostatus, 25.0% (n = 32) originated from 








Figure 3.6: Monthly trend of the total VIDA positive scrapes (n = 268) and sheep scab 
ELISA positive serostatus (n = 143), from February 2017 to August 2019 inclusive. Red 





Figure 3.7: Spatial distribution of the VIDA positive scrapes (n = 260) 
represented by the shaded regions, overlaid by points of the locations of 




In this chapter, data from a new diagnostic sheep scab ELISA were collated and analysed 
for the first time to create a new data source for the scanning surveillance of sheep scab. 
These data were also utilised to provide information on its use and uptake since 
commercialisation and to investigate the risk of sheep scab associated with particular 
management factors. As would be expected of a new diagnostic test, the number of 
submissions increased significantly across the study period. Seasonal fluctuations in the 
submission rate were also present, with the highest number of submissions occurring in the 
autumn and winter months. This seasonal pattern is well established for sheep scab, thought 
to be caused by particular climatic and management factors (French et al., 1999). Although, 
here, increased submissions across autumn and winter may have also been influenced by 
having easier access to sheep for blood sampling in winter due to housing or gathering for 
other seasonal management tasks. The sheep scab ELISA is still a relatively new option for 
the diagnosis of sheep scab in comparison to the existing skin scraping methodology, hence 
awareness of the test is still being established. The highest number of submissions, received 
in the last month of the study period, is an encouraging result for the further uptake of this 
new diagnostic test to reaching its full potential in the near future.  
As 12-sample submissions are recommended to achieve an accurate estimation of a flock’s 
serostatus, it is promising that these were the most frequently recorded. In addition, 66% of 
the 12-sample submissions were made for monitoring purposes, while no single submissions 
were made for monitoring purposes. It is likely this is a result of effective knowledge transfer 
campaigns undertaken by Biobest and MRI to promote the test and to provide guidance on 
its use. As well as through education, the compliance may have been further encouraged by 
offering discounted testing when 12 samples were presented. Currently it costs £6.00 per 
sample for 12-sample submissions (to a total of £72.00 for a 12-sample submission) as 
opposed to £9.00 for an individual sample submission, or £8.50 per sample for submissions 
with between 2 and 11 samples (Biobest, 2020). While the majority of submissions included 
12 samples, a large proportion included only one sample. As submissions with one sample 
were predominantly (87.5%) made to test itchy sheep (i.e. sheep with clinical signs), the use 
of a skin scrape test could have potentially offered a faster diagnosis in these cases. However, 
submission of a skin scraping sample to the APHA for testing (in England and Wales) costs 
significantly more than the blood sample at £24.70 per ectoparasite screen (APHA, 2020b). 
In addition, if lesions are not well-established on the sheep, skin scrapings can be difficult 
to perform and thus taking a blood sample would offer a much more convenient and reliable 
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alternative. For submissions containing between 2 and 11 samples, a possible explanation 
would have been not having enough sheep within the management group or not enough 
presented by the farmer for blood sampling, for example when testing quarantined animals, 
or to test a targeted group of animals with clinical signs. Hence, these results suggest a good 
overall understanding of the recommendation and purpose of the sheep scab ELISA from 
the submitting holdings. 
The sheep scab ELISA submissions were mostly concentrated in high prevalence areas such 
as Wales, North England and South West England (French et al., 1999; Rose et al., 2009). 
This pattern of uptake may have been influenced by an increased awareness of sheep scab 
in these areas, which is likely to have motivated holdings to develop a proactive monitoring 
strategy and ease the potential economic burden from outbreaks. This supports work which 
predicted that the sheep scab ELISA would be adopted in high-risk scenarios (Mohr et al., 
2020). In contrast, despite Biobest being based in Scotland and having shown a high number 
of VIDA positive scrapes diagnosed from Scotland over the same period, the number of 
submissions originating from Scotland was particularly low. It is possible that the uptake in 
Scotland over this time period was significantly affected by the free testing (through skin 
scrapings). Thus, under these circumstances, it would be uneconomic to use this test when 
there is a free option available. Another important factor to consider is the notifiable status 
of sheep scab in Scotland (see 2.3.4). As control was the primary reason for its introduction 
(Veterinary Record, 2010), in future it may be possible to incorporate the sheep scab ELISA 
into Scotland's surveillance strategy towards decreasing the prevalence of sheep scab and 
minimise the pressure on acaricidal treatments. However, this could present some 
challenging situations. As the sheep scab ELISA has been advocated for monitoring 
purposes, submissions could be part of a responsible proactive management strategy. If those 
submissions were to test positive, movement restrictions would be applied to the relevant 
flock(s) (The Scottish Government, 2010), meaning the use of the test could disadvantage 
farmers who are taking a proactive approach. Furthermore, as the sheep scab ELISA cannot 
differentiate between an active sheep scab outbreak and a successfully resolved outbreak 
(Hamer et al., 2019), there may be a possibility of false positive results, with potential 
implications on restriction of movements for the flock. As such, careful consideration over 
how to encourage a wider adoption of the sheep scab ELISA in Scotland must be taken so 
not to impair the income or willingness of responsible farmers. 
An important component of any serodiagnostic test is its interpretation, as OD provides a 
quantitative result for a single sample, but ultimately the veterinarian and farmer are 
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interested in a qualitative (yes or no) answer for the whole flock. Interpretation of the results 
at the flock level is currently undertaken by an experienced Biobest veterinarian, combining 
the OD results for the submission with the information provided on the submission forms. 
However, this is considerably time consuming and subjective, thus prone to human error. 
The new framework for the interpretation of the OD results applied a singular value of prior 
risk, 10%, to echo the current estimated national prevalence of sheep scab (Bisdorff et al., 
2006) and calculate the overall submission serostatus from the individual OD results. This 
produces an automatic outcome of positive or negative, which could provide a more 
standardised approach and be used to cut the time required for interpretation. Furthermore, 
this could become fully automated which would increase the timeliness of results delivery 
to farmers and decrease costs for Biobest. However, in practice, the risk of sheep scab is 
very individual and thus much more difficult to quantify. As shown using the existing 
scanning surveillance data in Chapter 2, and in previous studies using farm-level survey data 
(French et al., 1999; Rose et al., 2009), there is a high variability in risk dependent on 
geographical location. Likewise, the risk of sheep scab transmission varies between holdings 
dependent on their individual management practices (Rose and Wall, 2012; Vineer, 2011). 
A single prior value was utilised to create a framework to classify submission serostatus that 
was simple to implement across all submissions. However, as demonstrated by the analysis, 
prevalence was appreciably different across the three countries. Therefore, future work to 
refine with this framework could be aimed at including the regional variation of risk, utilising 
previous survey work (Rose et al., 2009) and/or consider using the management data 
included on the submission form to tailor the calculated submission serostatus to each 
submission's risk profile. 
A further objective of this chapter was to explore the ability of this data to determine 
potential risk factors associated with sheep scab infestations, which could also inform the 
risk factors utilised when calculating the submission serostatus. Unexpectedly, this study 
showed the use of common grazing, a well-accepted and proven risk factor for increasing 
the likelihood of sheep scab outbreaks (Cross et al., 2010; Rose and Wall, 2012), was not a 
significant predictor of the submission's serostatus. Hill holdings, which more frequently 
have access to common grazing, made submissions for monitoring in 60% of cases. In this 
instance, the lack of an association may suggest these holdings, which are taking a proactive 
approach to their sheep scab management by monitoring, have reduced outbreaks. In 
contrast, lowland holdings predominantly (76%) submitted due to suspected cases. 
Therefore, lowland submissions, where common grazing is unlikely, may have had a higher 
rate of positive serostatus submissions which could have influenced the model's accuracy. 
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Furthermore, the use of contract dipping was shown to have a marginal effect on increasing 
the likelihood of sheep scab infestations. While the introduction of persons and equipment 
onto a premise does present some risk to the holding, contract dipping is used as a treatment 
for sheep scab. Thus, contract dipping is only undertaken if ectoparasitic diseases such as 
sheep scab or lice have previously been suspected, or as part of prophylactic measures. As 
holdings which had previously suspected sheep scab were significantly more likely to have 
a positive serostatus submission, the past use of contract dipping to control sheep scab may 
account for its effect here. However, it is also likely that a number of further biases relating 
to the submitting population due to the voluntary nature of these diagnostic submissions may 
also influenced the ability of this model to predict the risk factors associated with a positive 
submission. 
Double fencing is recommended as a good biosecurity practice to decrease the likelihood of 
direct transmission for many infectious diseases, such as bovine tuberculosis (O’Hagan et 
al., 2016). As such, the use of double fencing is commonly recommended to decrease the 
risk of sheep scab (Sustainable Control of Parasites in Sheep [SCOPS], 2020). Here, the use 
of double fencing showed a significant negative association to a positive submission, 
indicating that the use of double fencing is associated with a reduced likelihood of sheep 
scab. 
In addition to investigating the current use of the sheep scab ELISA, a further objective was 
to assess the potential added value of the sheep scab ELISA data as an additional source of 
scanning surveillance. Despite its relatively recent commercialisation, the uptake was similar 
to the skin scrape test as the temporal pattern and total number of positive serostatus 
submissions was very similar to the number of VIDA positive scrapes with the exception of 
a spike in VIDA positive scrapes from December 2017 to April 2018. This spike was likely 
caused by the APHA free testing initiative as previously discussed in Chapter 2 (Figure 2.7). 
As the trend in positive serostatus submissions is very similar to the current well-established 
database despite their different diagnostic methods, this could support the use of the sheep 
scab ELISA to complement the current surveillance for sheep scab in GB. Yet, spatially the 
positive serostatus submissions captured a slightly different demographic, with a much 
higher proportion of positive serostatus submissions originating from England in comparison 
to the VIDA positive scrapes (70% vs 15% respectively). The high number of positive 
serostatus submissions in these areas may be a result of the sheep scab ELISA detecting 
subclinical cases, where a skin scraping may not have been an appropriate option. As a result, 
the sheep scab ELISA would capture a different cohort, which would support its future use 
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as complementary source of scanning surveillance for sheep scab. Furthermore, as the sheep 
scab ELISA is recommended for monitoring purposes, the sheep scab ELISA offers an easily 
extractable denominator (‘overall submissions’) which could provide an estimation of the 
prevalence of sheep scab across the UK. 
The proportion of submissions with a positive serostatus (43%) was higher than previous 
estimates from scanning surveillance and survey data (ranging from 9% to 36%) (Bisdorff 
et al., 2006; Cross et al., 2010; Rose et al., 2009), whilst the number of positive individual 
blood samples (14%), as categorised by their OD results, aligned more closely with current 
prevalence estimates (Bisdorff et al., 2006; Rose et al., 2009). In the case of sheep scab, even 
if a minority of animals within a flock are positive the whole flock status is interpreted as 
positive. This emphasises the intrinsic differences between the picture of sheep scab 
presented through the skin scraping method, used in the VIDA database, and sheep scab 
ELISA. The sheep scab ELISA adopts a flock level approach by taking multiple samples for 
monitoring, which means it is able to provide a powerful estimation of the flock level 
serostatus, even under low level infestation and subclinical disease (Hamer et al., 2019). A 
negative submission can therefore also be a reliable indicator of the absence of infestation at 
that time point. In contrast, the VIDA detects mites from skin scrapes at an individual animal 
level, which are only conducted when clinical signs are obvious. In addition, the result of 
the skin scrape test is also reliant on the initial quality of the scrape. As a consequence, false 
negatives results are more likely to occur. Thus, the data originating from the sheep scab 
ELISA, while sharing some of the limitations of the VIDA database (i.e. voluntary 
submissions), also presents some considerable benefits, like the high sensitivity of the test 
and the flock level diagnosis. 
A major part of this study, which enabled all of the above analyses, was the collation of the 
data to provide a new usable source of data for scanning surveillance. The created data source 
includes all sample results and all information from usable submission forms, which presents 
an unprecedented opportunity for more extensive analysis and a very valuable tool for 
evidence-based recommendations for future control strategies. However, as is often the case 
with data which was not intended for these purposes, the work required for the collation and 
formatting was significant and may provide a substantial barrier to their future use 
(VanderWaal et al., 2017). As the submission forms were hand-written and the location of 
certain elements were not consistent (e.g. location of the 6-digit submission number on the 
submission form), no software could be applied for their automatic digitisation. It was 
estimated that digitisation of all 542 submissions consisting of 3,089 blood samples (from 
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15 months of records) took in excess of 130 hours. This was approximately divided into: 20 
hours digitising the result report, 60 hours digitising the submission forms and a further 50 
hours on data cleaning to convert the data into a useable format for analysis. Therefore, 
continued analysis of these data as part of a more formal surveillance system would require 
substantial changes to their collection and storage to decrease the time and labour required. 
Ideally, a fully integrated digital system for data collection, such as is used for electronic 
patient records in human healthcare settings (Terry et al., 2019), could be adopted to increase 
the accessibility of the data. This would require the farmers to complete the submission form 
online using a computer, tablet or smartphone which would link to the unique 6-digit 
submission number used in the laboratory for the results. The information entered would 
then auto-populate a database, largely mitigating the time required for data cleaning whilst 
allowing the results to be integrated easily. In addition, the use of mandatory fields within 
the digital submission forms would likely increase the overall completion from the current 
median of 44% and thus increase the value of the collected data for scanning surveillance 
purposes. This would be particularly beneficial for the variables on the second page which 
were more often incomplete. However, changing the systems to become fully digital would 
require a complete overhaul of the current workflow and may not provide sufficient 
commercial value. In addition, it is also possible that requiring farmers and veterinarians to 
complete this information may discourage the use of thee sheep scab ELISA and thus hinder 
its uptake. Alternatively, and perhaps more feasibly, smaller changes to current practices 
could offer a more practical interim solution. These could include altering the submission 
forms to reduce ambiguity, such as providing tick boxes and an escape option to the fields 
which currently require circling. Also, it may be possible to implement an optical character 
recognition software to automatically extract the hand written information (Ridge, 2015) to 
limit time spent on data interpretation and extraction, thus reducing the costs of labour. 
Furthermore, the submission forms could be optimised to reduce the number of fields that 
are essential for the interpretation of the form in relation to the risk profile of the holding. 
In conclusion, this part of the research showed a steady uptake in the use of the sheep scab 
ELISA since the beginning of testing with an established seasonal pattern and broad uptake 
among England and Wales, but with few submissions originating from Scotland. The 
recommended 12-sample submissions for monitoring were the most frequently submitted, 
showing a good awareness of this test's application. As the majority of submissions were 
made from itchy sheep, this test is also widely used to diagnose sheep scab in sheep with 
clinical or subclinical signs. This study also showed a negative association between double 
fencing and a positive scab serostatus; however, common grazing was not identified as a risk 
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factor. Furthermore, the positive serostatus submissions showed a very similar temporal 
pattern to the existing scanning surveillance (VIDA positive scrapes). Finally, this study 
created a new database using data from the recently commercialised sheep scab ELISA 
which could be further utilised as an evidence-base towards improving approaches to the 




4. General discussion 
Endemic diseases are, unfortunately, a very familiar problem in modern livestock farming, 
with their effect felt throughout the industry. However, with an ever-increasing pool of 
available data as farming moves into the digital age (VanderWaal et al., 2017), the enhanced 
use of these data may present new opportunities to develop a valuable, cost-effective and 
evidence-based platform to inform the future management of endemic diseases (Bennett and 
IJpelaar, 2005; Gates et al., 2015). Using sheep scab as a model,  this research project aimed 
to provide an example of this potential. By using existing surveillance data and evaluating a 
new data source, our knowledge and understanding of this endemic disease has been 
enhanced, specifically towards improving control strategies for sheep scab.  
At present, improving the use of existing scanning surveillance data may present the most 
accessible route to improving the management of endemic diseases. The VIDA database, as 
described in Chapter 2, currently provides scanning surveillance for many diseases across 
GB. Like most established databases, it is presented in a standardised format which decreases 
the time required for data cleaning, facilitating easier analysis. Therefore, exploiting these 
data further could provide a cost-efficient approach to improving current surveillance 
outputs. As demonstrated through the application of the TADA analysis in Chapter 2, there 
is significant potential to use this source to fulfil more specific objectives, such as the 
evaluation of past disease control initiatives. Dependent on the specific disease, exploiting 
existing data sources further might provide sufficient information and contribute towards the 
final objective of improving the control of an endemic disease, whether this is to decrease 
the prevalence or eradication. If the existing source, however, is not sufficient on its own, 
new data sources should be explored and taken advantage of.  
Accessing and utilising new data sources is usually more challenging, but could have the 
potential to add significant value to the existing scanning surveillance. As demonstrated in 
Chapter 3, the work required to create valuable information from a new data source was 
considerably time-consuming (Barrett, 2017; McCue and McCoy, 2017; Schneeweiss, 
2014), however can be very rewarding. Crucially, the work undertaken to produce the new 
data source in Chapter 3 resulted in the creation of an extensive database which has provided 
further knowledge to inform some crucial aspects of sheep scab management. For other 
diseases, when selecting possible sources of new data, it is likely there will be a high 
variability in the pre-processing work required, dependent on the current data management 
practices employed (Sun et al., 2018). Thus, if multiple sources are available, it may be 
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possible to select sources which require the least pre-processing, or those where technology 
could be employed to streamline the pre-processing. Despite the inevitable initial outlay 
required to create these data sources, it is quite possible that if the source is selected carefully, 
these costs would be recovered if the control strategies of these diseases were to be improved 
as a direct result of their analysis. Therefore, data sources should not be dismissed purely on 
their degree of accessibility, as their benefit could outweigh the initial costs. Instead, a 
balance needs to be achieved to estimate the value of these sources, with potential incentives 
from government or public funding to promote good data management and sharing of data. 
For sheep scab, there is currently a high degree of motivation throughout the industry to 
reduce the prevalence of this disease, particularly in "hotspot" areas. To create a cost-
effective evidence-base to inform these control strategies, improving the use of available 
data is considered a priority by stakeholders. The new database produced in this research 
project was collated through collaboration with Biobest as part of a wider project driven by 
the emergence of antiparasitic resistance. This multi-disciplinary project funded by the VMD 
(DEFRA – VMD Lot 2 Antiparasitic Resistance: Sheep Scab) aims to guide the development 
of targeted and coordinated activities across the industry. Beyond this project, other 
management strategies have been, and are currently being developed by government and 
industry. These include the Sheep Scab (Scotland) Order 2010 which was introduced as a 
result of industry pressure (Animal Health and Welfare Wales, 2018; The Scottish 
Government, 2010), and a recently announced £5 million funding package from the Welsh 
Government, to aid eradication of sheep scab in Wales (Vet Times, 2019), a major hotspot 
for outbreaks. Furthermore, in January 2020, a meeting was hosted by the University of 
Bristol which assembled a group of stakeholders including farmers, veterinarians, 
government, industry and researchers to consider options for future sheep scab management 
in GB.  
To date, the approach towards achieving sheep scab control has been driven by targeted 
initiatives organised and funded by government and industry bodies, as outlined in Chapter 
2. It is likely that in absence of a national eradication scheme, targeted initiatives will 
continue to be the primary tool towards control. The evidence presented in this project could, 
however, guide their evaluation and implementation in a cost-effective manner. The use of 
free skin scraping testing, for example, would capture the attention of farmers in the short 
term, with the aim to increase submission from suspected cases. If the sheep scab ELISA 
was included when offering free testing, this would also allow capture of subclinical cases, 
which are important reservoirs of mites (Hamer et al., 2019), and may encourage farmers to 
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adopt a more proactive strategy through regular monitoring of their flocks. If sheep scab was 
diagnosed, support should be provided to ensure the correct treatment is applied, to decrease 
the selection pressure on acaricidal drugs resulting from incorrect use. This also raises the 
importance of education, through knowledge transfer or knowledge exchange campaigns 
(Farm Animal Welfare Committee, 2011), to emphasise the importance of good biosecurity 
measures, such as double fencing, as shown in Chapter 3. Practically, all these initiatives are 
expensive and labour intensive. Initially, however, efforts could be targeted in hotspot 
regions such as Wales, as identified in Chapter 2. As it has been previously shown, targeted 
approaches for sheep scab control are more effective, as they encourage a collaborative 
approach amongst neighbours (Sargison et al., 2006). This was also demonstrated on a 
smaller scale, by using the sheep scab ELISA to test seven flocks of Herdwick sheep sharing 
a common grazing, a targeted project coordinated by a local veterinarian (APHA, 2019; A 
Carson, personal communication). In this case, the sheep scab ELISA detected subclinical 
disease in five of the holdings, highlighting the importance of the early detection of 
subclinical disease, and encouraging local cooperation between holdings.  
Compliance is also a particular issue for sheep scab, as control is very reliant on strategies 
adopted by neighbours (Nixon et al., 2017). Additionally, sheep scab has been stigmatised 
as a disease related to poor management and is therefore not as openly discussed as other 
endemic diseases (Cross et al., 2010). For that reason, action plans could be more consumer-
led, providing economic reward for responsible farmers. This could be achieved through the 
deployment of an accreditation scheme similar to the Enzootic Abortion of Ewes (EAE) 
accreditation scheme in Scotland (SRUC, 2020), which rewards members of these schemes 
with higher prices paid at markets. Regardless of the strategies selected, the control of sheep 
scab will not be achieved in the short term, therefore commitment and sustainability are of 
paramount importance.  
In conclusion, this research has achieved the aim to enhance the use of existing and new data 
sources for the scanning surveillance of sheep scab, specifically to guide future control 
strategies. It has exploited an existing scanning surveillance data source, the VIDA database, 
to identify disease "hotspots" in Wales, which could be the focus for more targeted disease 
control efforts. It has also shown other potential outcomes from the existing data, through 
the use of a TADA to show that free testing had the largest impact on positive scrapes. In 
addition, it has provided information on the current use and uptake of the sheep scab ELISA, 
demonstrating a good awareness of this test's application for monitoring, while also being 
widely adopted to diagnose sheep with clinical signs. Furthermore, this new data source 
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showed the presence of double fencing is significantly associated with a decreased the risk 
of infestation. Lastly, this project resulted in the creation of a new data source that could be 
used to complement the existing surveillance data of sheep scab. Ultimately, the framework 




Appendix 1: Monthly aggregate of positive scrapes from 










Month 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 TOTAL
January 35 72 33 34 52 28 26 33 34 23 11 13 4 17 18 42 475
February 35 51 32 30 42 26 20 18 19 18 13 6 4 13 8 44 379
March 21 26 31 18 19 13 19 26 10 9 8 5 3 4 3 26 241
April 8 9 19 12 10 16 3 10 5 9 2 2 4 8 3 11 131
May 10 5 12 6 8 3 4 6 1 3 0 3 3 1 2 3 70
June 3 7 7 7 8 7 2 4 2 2 2 1 4 2 2 2 62
July 9 9 8 1 13 10 6 8 4 3 2 2 3 4 4 0 86
August 5 11 9 13 10 11 4 9 11 3 6 4 10 5 2 2 115
September 8 8 7 9 14 20 14 12 6 9 7 3 7 3 3 7 137
October 14 22 20 10 15 13 11 15 9 7 5 5 4 1 7 12 170
November 31 26 34 22 20 18 14 17 13 12 8 8 4 8 6 9 250
December 45 31 37 30 20 19 17 21 9 8 6 8 5 5 10 14 285
TOTAL 224 277 249 192 231 184 140 179 123 106 70 60 55 71 68 172
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Appendix 4: Sheep scab ELISA submission form 














Appendix 6: Fields digitised from the sheep scab ELISA 
submission forms.  
* denotes variables that were captured but not subsequently and further analysed in this 
thesis. 
Field Description 
Holding number* The unique county parish holding (CPH) 
number of the submitting holding, captured to 
parish level to maintain anonymity. 
Postcode* Postal code of the holding. 
Vet practice Submitting veterinary practice. 
Reason for testing* Reason for submission. Reasons included: 
diagnosis for itchy sheep (clinical signs), 
monitoring clinically normal sheep, testing 
quarantined sheep, and 'other'. 
Farm type* Primary land type of the holding: hill, upland, 
lowland, or a combination of the three. 
Flock size Number of breeding ewes 
Date of last acaricide treatment Date of last product used against sheep scab 
Last acaricide product given Product used (brand name or compound) 
Use of organophosphate dip Was an organophosphate dip used within the 
past 12 months? 
Month of last organophosphate dip If given in the last 12 months, in what month was 
the product administered? 
Use of organophosphate shower Was an organophosphate shower used within the 
past 12 months? 
Month of last organophosphate 
shower 
If given in the last 12 months, in what month was 
the product administered? 
Use of injectable macrocyclic lactone Was an injectable macrocyclic lactone product 
used within the last 12 months? 
Month of last injectable macrocyclic 
lactone use 
If given in the last 12 months, in what month was 
the product administered? 
Double fencing* Are all farm boundaries double fenced where 
there may be contact with other livestock? 
Common grazing* Is common grazing used? 
Contract shearing* Are contract shearers used? 
Contract dipping* Are contract dip operators used? 
Shared gathering facilities* Are shared gathering facilities used? 
Shared livestock trailers* Are shared livestock trailers used? 
Other management factors allowing 
contact with other sheep* 
Free text area to list other management factors 
and potential risk factors not listed on the form. 
Also lists any schemes or vouchers for free or 
subsidised submissions. 
New stock – treatment upon arrival Are new stock treated with a product active 
against sheep scab upon arrival? 
New stock – treatment product If yes, what treatment product is used upon 
arrival? (brand or compound name) 
New stock- quarantine period How long are purchased sheep kept separate 
from the home flock? 




Treatment product – Tack If sheep are treated upon return from tack, what 
product is used? 
Quarantine – Tack How long are sheep quarantined for upon return 
from tack? 
Treatment – Mart Are sheep treated upon return from the mart? 
Treatment product – Mart If sheep are treated upon return from the mart, 
what product is used? 
Quarantine – Mart How long are sheep quarantined for upon return 
from the mart?* 
Treatment – Shows Are sheep treated upon return from shows?* 
Treatment product – Shows If sheep are treated upon return from shows, 
what product is used?* 
Quarantine – Shows Are sheep quarantined upon return from 
shows?* 
Sheep scab previously diagnosed* Was sheep scab diagnosed in the 2 years prior to 
submission? 
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